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A B S T R A C T
As life expectancy has risen steadily over the last years and disease-
free aging is more and more challenging, understanding the com-
plexity of age and aging is of great importance. Metabolomics is one
of the novel approaches in systems biology with high potential to
deliver answers to these questions. However, only a few metabolic
studies based on large samples are available so far.
In this thesis, I present results from two population-based studies,
the German KORA Follow-Up 4 (KORA F4) study as a discovery co-
hort with a sample of 1,038 female and 1,124 male healthy partici-
pants (32–81 years) and 724 healthy females from UK Adult Twin
Registry (TwinsUK) as replication. Targeted metabolomics of fasting
serum samples with flow injection analysis coupled with tandem
mass spectrometry (FIA-MS/MS) positively quantified 131 metabolites
after stringent quality control. Among these, 71 and 34 metabolites
were significantly associated with age in females and males, respec-
tively , after adjustment for body mass index (BMI), which is highly
correlated (r=0.9) with age.
These results indicate that metabolic profiles are age dependent and
sex specific. Then, a set of the 12 most age-discriminative, indepen-
dent metabolites was identified in women with an approach based on
random forest and stepwise variable selection. This set showed highly
significant differences between subjects aged 32–51 years and 52–77
(p-values range 1.3E-09 – 1.9E-46, significance threshold p=0.004). Ten
out of these 12 metabolites replicated in unrelated females from the
TwinsUK study, including five metabolites the concentrations of which
increased with age (C12:1, C18:1, sphingomyelin (SM) C16:1, SM C18:1
and phosphatidylcholine (PC) aa C28:1), while histidine decreased
gradually. Three glycerophospholipids (PC ae C42:4, PC ae C42:5, PC
ae C44:4) showed declines around the age of 51 years. Meta-analysis
of both studies gave virtually the same results as KORA alone.
These observations might reflect many different processes of aging
such as incomplete mitochondrial fatty acid oxidation, counteracting
oxidative stress, and changes in vascular functions. The identification
of these ten age-related metabolites should help better understand
aging pathways and networks and with —more discoveries in the
future— eventually help enhance healthy aging and longevity.
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Z U S A M M E N FA S S U N G
Die Lebenserwartung nimmt in den letzten Jahren stetig zu und gesun-
des Altern wird dadurch zu einer immer größeren Herausforderung.
Daher ist das Verständnis der Komplexität des Alterungsprozesses
von großer Bedeutung. Metabolomics ist einer der neuartigen Meth-
oden in der Systembiologie, die ein großes Potential mitbringt, um
diese Probleme zu bewerkstelligen. Bisher sind jedoch kaum pop-
ulationsbasierte Metabolomics-Studien veröffentlicht, die auf einer
großen Fallzahl beruhen.
In dieser Doktorarbeit stelle ich die Ergebnisse zweier populations-
basierten Studien vor, zum einen aus der deutschen KORA F4-Studie,
die mit 1.038 gesunden Frauen und 1.124 gesunden Männern im
Alter von 32 bis 81 Jahren als Untersuchungskohorte diente, und
zum anderen aus der englischen TwinsUK-Studie, deren 724 gesunde
Frauen zur Replikation meiner Ergebnisse dienten. Die Nüchtern-
Serum-Proben wurden mittels gezielter Metabolomics-Messungen
(FIA-MS/MS) analysiert und nach strenger Qualitätskontrolle konnten
131 Metaboliten quantifiziert werden. Darunter waren 71 bzw. 34 Me-
tabolite signifikant mit dem Alter in Frauen bzw. Männern assoziiert,
nachdem für den BMI adjustiert worden war. Der BMI ist stark mit
dem Alter korreliert (r=0,9).
Diese Ergebnisse deuten darauf hin, dass die metabolischen Profile
sowohl altersabhängig als auch geschlechtsspezifisch sind. Daraufhin
konnte ein Set aus 12 Metaboliten in Frauen ermittelt werden, das
hochsignifikante Unterschiede zwischen Frauen in der Altergruppe
32–51 und in der Altergruppe 52–77 zeigte (p-Wert-Spanne 1,3E-09 –
1,9E-46, korrigiertes α of 0,004). Zehn dieser 12 Metaboliten konnten
in den nicht-verwandten Frauen der TwinsUK-Studie repliziert werden.
Darunter waren fünf Metabolitenkonzentrationen, die mit dem Alter
anstiegen (C12:1, C18:1, SM C16:1, SM C18:1 und PC aa C28:1), die His-
tidinkonzentration dahingegen fiel allmählich ab. Drei Glycerophos-
pholipide (PC ae C42:4, PC ae C42:5, PC ae C44:4) wiesen Konzentra-
tionsabfälle um ein Alter von 51 Jahren auf. Eine Metaanalyse beider
Studien erbrachte mit den KORA F4-Ergebnissen vergleichbare Resul-
tate.
Diese Beobachtungen spiegeln möglicherweise viele verschiedene Al-
terungsprozesse wider, wie zum Beispiel eine unvollständige Oxida-
tion der Fettsäuren, das Entgegenwirken von oxidativem Stress, und
Veränderungen in den Gefäßfunktionen. Die Identifikation dieser al-
tersassoziierten Metabolite kann helfen, alterungsbetroffene Stoffwech-
selwege und Netzwerke besser zu verstehen und zusammen mit wei-
teren zukünftigen Forschungsergebnissen letztlich dazu beitragen, ge-
sundes Altern und gesunde Langlebigkeit zu fördern.
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Aging can be fun if you lay back and enjoy it.
— Clint Eastwood
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I N T R O D U C T I O N
1.1 aging - definition, demographics , and molecular bi-
ology
1.1.1 Definition and demography
Aging describes a biological process that every human being encoun-
ters. The term ‘aging’ itself is on the one hand very familiar to ev-
eryone but on the other hand lacks in a common scientific definition.
Many suggestions are made, the common idea of a complex, time- Different definitions
dependent process with various changes and associated risks might
be well described by Simm et al. in 2008 [70] though it is quite gen-
eral1:
[T]he ageing process [. . . ] can be defined as a time-depen-
dent decline of functional capacity and stress resistance
associated with increased risk of morbidity and mortality.
Ageing is a complex process and affects most if not all
tissues and organs of the body.
Following this definition, aging is an all-embracing transformation of
an organism. The generality of this definition might mirror the gaps
in capturing and understanding the aging process in its entirety. Nev-
ertheless there are, of course, also more uncommon points of view. Fa-
mous gerontologist Leonard Hayflick, for example, provided a very
physico-chemical sight on the process in 2007 [32]:
Aging is an increase in molecular disorder. It is a stochas-
tic process that occurs systemically after reproductive ma-
turity in animals that reach a fixed size in adulthood. This
escalating loss of molecular fidelity ultimately exceeds re-
pair and turnover capacity and increases vulnerability to
pathology or age-associated diseases. The fundamental cause
of molecular disorder is rooted in the intrinsic thermo-
dynamic instability of most complex biological molecules
[. . . ].
More details on his ideas on a indispensable entropic cause of aging
are given in section 1.1.2. The difficulties of definition also seem to
reflect that underlying processes have not been fully understood and
disentangled, yet, although Hayflick in his forecited article even states
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Figure 1: Development of world’s age structure.
Age structure of the world population has been changing remark-
ably over the last 50 years and is predicted to continue in this
way[81]. Reprinted with the permission of the United Nations.
Figure 2: Development of world’s proportion of elderly.
Proportion of the elderly (>60 yrs.) is predicted to remarkably
grow in all parts of the world in a quarter of a century [51].
Reprinted with the permission of the MIT age lab.
that it is understood2. However, understanding aging’s biochemistry
in detail will gain importance as life expectancy of humans and hence
percentage of elderly people has permanently risen throughout the
world during the past century [25, 81]. Figures 1 and 2 show that thisDemography
process is expected to go on in the future. The proportion of persons
aged 60+ years of total world population is predicted to grow from
11% in 2012 to 22% in 2050 [82]. By 2050, older people (60+ years) will
outnumber the population of children.
The aging population entails great challenges for world population
in health, economics, and brings up social issues [10, 83]. Particularly
health care systems will be challenged in the future as aging is of-
ten accompanied by disabilities (e. g., vision and hearing impairment,
cognitive decline, physical limitations in standing, reaching, grasping)
and diseases (e. g., cancer, cardiovascular disease (CVD), chronic lower
2 The pursuit of entropy of all molecules also causes aging.
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respiratory tract disease, Alzheimer’s disease, chronic joint symp-
toms, arthritis, and diabetes)[25]. Also, co-morbidity is common along
with old age. Therefore, understanding the physiology and biochem-
istry of aging is of tremendous importance to detect and combat
pathological deviations and eventually permit a preferably disease-
free senescence with a good quality of life.
1.1.2 Overview of main aging theories
As it has become apparent in the definitions above, many transforma-
tions happen in the aging process to the human organism that affect
all levels from organ systems to cell organelles and lead to a wide
variety of altered functions. Genetics and environmental influences
seem to be involved in the process, but insights from different points
of view are imperatively desired [41, 42, 64]. Popular theories of aging
include oxidative stress theory (refinement of the free radical theory
from 1956), theory of accumulation of glycated proteins (advanced
glycation end-products (AGEs)), involvement of chronic low-grade in-
flammation, altered impact of several hormones, and chromosome
telomere shortening [70, 76, 92, 28, 62, 40]. Still the largest part of
knowledge stems from cell culture studies and studies in C. elegans,
Drosophila, rat, and mice, but not from human studies. However, for
the wide scientific field of aging one common consensus theory is
not found so far [7].The mentioned theories should be explained in a
short, simplified manner subsequently.
oxidative stress theory [70, 53]: An unpaired electron char-
acterizes reactive oxygen species (ROS) making them highly reactive
and thus liable to strip electrons from other molecules, which in
turn become radicals, and so forth, resulting in damaged proteins,
membranes and nucleic acids. A prominent product is 8-hydroxy-29-
deoxyguanosine that may lead to altered gene expression via muta-
tion of the deoxyribonucleic acid (DNA) and is employed as a marker
for oxidative stress. ROS are mainly produced in the mitochondrial
respiratory chain. Besides ROS, other forms of activated oxygen like
peroxides and aldehydes contribute to total oxidative stress.
theory of accumulation of glycated proteins [70, 92, 69]:
In a non-enzymatic reaction, a sugar molecule is bonded to a protein
or lipid molecule forming, e. g., carboxymethyl lysine and pentosine,
which both are employed as markers of AGE accumulation. This re-
action creates protease-resistant cross-links of proteins. AGEs can acti-
vate cells and thereby lead to ROS generation. Inversely, ROS may also
induce formation of AGEs.
chronic low-grade inflammation [70, 28]: Both the innate
and the adaptive immune system are activated with older age to-
gether with increasing levels of proinflammatory cytokines (e. g., TNFα
4 introduction
and IL-6). Thereby, changes in innate immunity result in a chronic
low-grade inflammation and alterations in adaptive immunity lead
to accumulation of megaclones of memory cells, occupy immunolog-
ical space and thus lead to decreased t-cell repertoire.
altered impact of several hormones [70, 62]: Secretion and
tissue responsiveness of growth hormone (GH) (esp. via release of
insulin-like growth factor 1 (IGF1)) decline with aging, which is associ-
ated with obesity, loss of muscle mass, and with higher antioxidative
capacity. Decreased levels of insulin during aging are associated with
caloric restriction (CR) in mammals and with normal to low glucose
levels resulting in improved insulin sensitivity and longevity. The
dehydroepiandrosterone (DHEA) is the precursor of sex hormones in pe-
ripheral tissues (others than ovary and testes). Its levels decrease with
age, but supplementation has neither positive nor negative effects on
different health outcomes, whereas declining levels of its sulfate (de-
hydroepiandrosterone sulfate (DHEAS)) are associated with death in
general and death from CVD. Estrogen levels decrease after menopause
accompanied by increased risk of cardiovascular events, loss of skele-
tal mass, vasomotoric instability, psychological symptoms and atro-
phy of estrogen-responsive tissue. Testosterone decrease is associated
with an increase in fat mass, loss of muscle and bone mass, fatigue,
depression, anemia, poor libido, erectile deficiency, insulin resistance
and higher cardiovascular risk.
chromosome telomere shortening [70, 40]: Telomere shortening
is the main cause of cellular senescence3 and is itself caused by inabil-
ity of DNA polymerases to prime DNA synthesis in this region during
cell division in somatic cells4 and also by oxidative stress. As telom-
eres have a protective effect on the DNA it is supposed that telomere
shortening has effects on morbidity and mortality but results are in-
consistent.
Following the forecited Hayflick paper [32], there are two majorHayflick’s aging
theory classes of aging theories, according to his considerations in the pa-
per, only one of the two is tenable. He argues that there is no direct
evidence for a gene-driven age change within the meaning of a pre-
determined program, but evidence exists for aging as a stochastic
process that is characterized by a ’loss of molecular fidelity’. The au-
thor brings forward the argument that all molecules follow their ther-
modynamic features by loosing energy (idea of entropy) and thus
constantly change. Definition of biological aging (in contrast to aging
of non-living things) is extended by the repair systems, that are them-
selves prone to aging processes, resulting in the aging definition cited
at the beginning of this chapter.
Processes that can be assigned to this theory of aging are glycation
3 Arrest of cell cycle and growth after a certain time in culture, altered gene expression,
allocation of the phenomenon to the whole organism is speculated.
4 Stem cells possess telomerase, which is able to maintain telomere length. Embryonic
stem cells have full telomerase function whereas it is limited in adult stem cells.
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processes (formation of AGEs), changes in three-dimensional structure
of molecules, different aggregations, amyloid formations, alterations
in metabolic processes like protein degradation and synthesis rates,
as well as damages and modifications on nuclear and mitochondrial
DNA (e. g., telomere shortening, damages due to ROS). However, ge-
netic influence comes into the discussion again with determinants of
longevity. Hayflick explains that this is not a stochastic process like
aging, but gene-governed levels of physiological capacity, repair, and
turnover indirectly determine potential longevity. Although Hayflick
argues that the cause of aging is disentangled, I hold the view that
consequences of these stochastic processes in terms of biochemical
pathways and others need to be explored. Especially, there is room for
studies in humans although other models are easier to follow through
their lifespan.
1.1.3 Current knowledge of the metabolism of the elderly
As early as 1908, Max Rubner suggested a link between metabolic
rate/oxygen consumption and lifespan in eutherian mammals, which
was refined by Pearl to the rate of living theory in 1928 [35, 53]. Al-
though the rate of living theory is no longer accepted, it can be seen
as a start point of research into the aging metabolism. Today’s state
of knowledge is outlined in this subsection.
Body composition and anthropometry of aging individuals expe- Global changes
rience changes. Body fat content rises most notably in abdominal re-
gions, lean mass declines (both muscles and organs loose weight with
differing extent between organ systems), and all results in higher BMI
[80, 33, 68]. Together with changed endocrine functions, anthropomet-
ric remodeling evokes that alterations accompanying older age are
also observable on metabolic levels. The basal metabolic rate (BMR)
is described to decline with aging though with large intra- and inter-
individual ranges, and diseases may increase BMR. Underlying rea-
sons might derive from lower muscle and organ masses. In a sys-
tems biology approach aiming the question of the interconnection
between development and aging, aerobic metabolism appears as a
major regulator, besides epigenetics and the immune system [24].
Glucose metabolism enzymes (glycerol-3-phosphate dehydrogenase
1 and 2), factors for glucose homeostasis (IGF1, mammalian target of
rapamycin (mTOR)) and citric acid cycle enzymes (succinate dehydro-
genase complex, aconitase) were highlighted.
Mechanistic insight into alterations in fat metabolism is given by Fat metabolism
an article on lipid metabolism of the elderly by Toth and Tchernof
[80]. Higher levels of free fatty acids (ffas) observed in elder subjects
are thought to contribute to age-associated body fat accumulation via
two different mechanisms: altered recruitment of fat substrates and
6 introduction
altered fat oxidation.
Study results from both aged rats and humans showed a reduced
stimulation of lipolysis by catecholamines (inhibition of lipolysis, how-
ever, was not affected by age). Release of ffas was not impaired, but
their release from adipose tissue exceeds energy needs of the elderly.
As the inhibitory effect of insulin on lipolysis declines with age and
ffa release is regulated by insulin (and others), a causal relationship
suggests itself. However, ffa rise may also simply result from larger
adipose tissue.
In elderly, fat oxidation decreases postabsorbtively, which might be
simply explained by reduced resting energy expenditure. But the ar-
ticle describes findings that showed impaired ability to increase fat
oxidation after a rise in ffa availability with older ages, e. g., in post-
prandial state. This impairment might come from a decline in fat free
mass (FFM)5, which decreases with age. As this only explains the de-
scent of resting energy expenditure, alterations in oxidative capacity
of FFM could also clarify the changes postprandial and during ex-
ercise. Glycolytic capacity of skeletal muscle, which represents FFM
during exercise, is found to be maintained with age, but activity of
enzymes of oxidative metabolism and β-oxidation of fatty acids are
reduced. The reduction in size of skeletal muscle with age add to
these declines.
Taken together, the age-related changes in lipid metabolism could
generate increased glucose production, impaired insulin-dependent
glucose uptake, and diminished hepatic insulin extraction. In turn,
these effects promote hyperinsulinemia and insulin resistance. Ather-
osclerotic processes would be enhanced by incorporation of not ox-
idized ffa into very low density protein (VLDL). In their article from
2009, Dennis et al. report that homeostatic set points of metabolic
feedback mechanisms for glucose and fatty acid metabolism are sub-
jects to age-dependent changes. This statement supports the mecha-
nisms described by Toth and Tchernoff [80]. Concerning amino acids
concentrations, both increases and decreases were reported in differ-
ent studies [46], what points to inconsistent data by the current state.
Further insights into aging metabolism were drawn from studies onHealthy
centenarians healthy centenarians (HCs). Paolisso and his group interpreted HCs as
subjects with a successful remodeling process during aging with effec-
tive mechanisms against age-related diseases [60, 4]. The reasons for
their success is unknown for the most part. Observations suggest that
significant improvement in glucose handling, especially ameliorated
insulin sensitivity and deteriorated IGF1 levels, plays a prominent role.
There is a number of factors likely involved:
5 Fat free mass is a proxy of mass of metabolically active tissue.
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• CR6: leads to lower body temperature, improved insulin sensi-
tivity via lowered fasting plasma glucose and insulin levels and
improved insulin action, lowers fasting plasma free IGF1 and
DHEA7 levels, improves thyroid function;
all resulting in lowered energy production in the mitochondrial
complex (ad libitum diet is associated with higher ROS produc-
tion that activates different mechanisms that then impair en-
zyme activity, CR acts oppositely: less ROS slow cellular aging
and reduce danger of DNA damage) and minimized DNA dam-
age, i. e., genomic stability
• changes in glucose metabolism: impaired glucose me-
tabolism due to a decline in insulin action, HCs have a very low
prevalence of insulin resistance
• anthropometric changes: HCs do not show the associa-
tion between elevated waist-hip ratio and insulin resistance or
dyslipidemia
• endocrine alterations: higher levels of free plasma IGF1 in
HCs than in control elderly subjects had positive effects on an-
thropometric and metabolic parameters; lower levels of leptin
in HC associated with lower body fat content; lower degree of
oxidative stress in HC along with higher plasma antioxidant de-
fense levels than elderly control subjects (mainly vitamin E)
Another interesting group for studying aging is the Ashkenazi
Jews, who live very isolated in the US (genetic homogeneity). Barzi-
lai et al. investigated a group of 213 healthy Ashkenazi Jews with
exceptional longevity aged between 95 and 107 years and one first-
degree offspring of each (216 individuals, 51–89years) [5] and addi-
tionally one Ashkenazi control group with “normal” longevity and
one population-based control group from the Framingham Offspring
Study. A focus of the study was lipoprotein levels in blood. The
long-living individuals showed clearly larger high density lipopro-
teins (HDL) and low density lipoprotein (LDL) particles independently
from absolute levels of lipoproteins and apolipoproteins resulting in
lower prevalences of hypertension, CVD, and metabolic syndrome.
This observation is suggested to contribute to the longevity. The mech-
anism behind might be that large LDL particles move more slowly into
arterial tissue, bind less tightly to arterial surface molecules, are less
prone to oxidation compared to small LDL and thus might protect
against endothelial dysfunction and CVD.
Upon findings from genetic studies in animal models, there are Pathways involved
in aging
6 The description in the papers is not completely clear, but I don’t think HCs have a
CR, but the corresponding effects and pathways might play a role in their successful
aging.
7 endogenous steroid hormone, precursor of sex steroids, advertized as anti-aging
hormone, further information in 1.1.2
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two nutrient-sensing pathways known to be involved in aging mech-
anisms across different species [61]. The target of rapamycin (TOR) path-
way regulates numerous processes in cell function, metabolism, tran-
scription and others and is attributed to have an evolutionary con-
served role in aging. Both TOR and its mammalian equivalent mTOR
are kinases inhibited through rapamycin8. In more detail, mTOR con-
trols cellular functions in response to growth factors and nutrients,
in particular amino acids (AAs) and among these especially leucine.
An interplay between mitochondrial dysfunction (through mitochon-
drial inhibitors, adenosine triphosphate (ATP) depletion) and mTOR is
possible via AMP kinase (AMPK)9 activation and subsequent mTOR-
p70α10 inhibition [79]. Modulation of mTOR in mice extended life-
span through delayed death from cancer, slowed aging mechanisms,
or both [31]. Another evolutionary conserved pathway is the insulin/
insulin-like growth factor signalling (IIS) pathway, that has been described
to balance nutrient consuming processes (e.g. growth, metabolism)
and nutrient availability [61] and is further involved in reproduction,
stress resistance, and diabetes development [63]. This pathway also
prolongs lifespan by delaying effects of aging.
Due to their central roles in nutrient-sensing pathways, mTOR and
IIS signaling might be the mechanisms behind the life-extending ef-
fect of CR [72]. CR inactivates one or more pathways partially that
would usually be activated by nutrients [27]. These inactivations may
lead to extended life-span. The existence of these mechanisms might
evolutionary be explained by a stop in cell division and reproduction
to save energy for maintenance systems during starvation.
1.2 metabolomics
1.2.1 Definitions
Metabolomics is a key technology of modern systems biology and
is targeted on an integral depiction of the current, i. e., time-related,
metabolic status of an organism, associated with physiological and
pathophysiological processes [65, 50]. The ideal is to measure all
metabolites of a sample, i. e., the so-called metabolome [1]. Differ-
ent technologies are in use, until now none capable of measuring
the whole metabolome. Hence, metabolomics divides into two differ-
ent approaches. Untargeted metabolomics is applied in hypothesis-targeted versus
untargeted free studies that focus on the comparison of two groups, e. g., ill
versus healthy probands, mostly with help of nuclear magnetic res-
8 Rapamycin is a drug that inhibits TOR and has anti-neoplastic effects.
9 AMPK senses the level of adenosine monophosphate (AMP) as a measure of cellular
energy status and activates energy conserving and producing pathways in response
to high levels.
10 p70α stands for the ribosomal protein S6 kinase from the family of serine/threonine
kinases and is activated by mTOR.
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onance (NMR). Targeted metabolomics is used in studies aiming at
specific pathways or known molecules, most often by application of
mass spectrometry (MS) with the restriction to a limited subset of the
metabolome [1, 75].
There is furthermore a subtle differentiation between the terms
metabolomics and metabonomics, albeit usage in the literature is not metabolomics versus
metabonomicsthat distinct [50]. In older definitions metabonomics was used for
plant studies and metabolomics for animal studies; a later definition
connects them to NMR and MS technologies, respectively. Although
Mishur and Rea write that the latter definition is outdated [50], many
others still apply it, e. g., Suhre and Gieger describe metabonomics
as a common synonym for NMR-based approaches [75]. Theodoridis
et al. even point out that the terms are often used interchangeably
and recommend terms like metabolite profiling instead [78]. As a
current definition Mishur and Rea specify metabonomics as the stud-
ies of dynamic changes in the metabolome caused by perturbations
by disease, drugs, or toxins and metabolomics as a metabolic snapshot
of the momentary metabolites in the sample. Obviously, these de-
scriptions overlay with those for targeted and untargeted approaches
given above. Summarizing this section so far, metabonomics is often
connected to NMR application in untargeted comparison of the dy-
namic metabolic changes of two study groups whereas metabolomics
often applies MS for targeting a selected subset of the metabolome.
All definitions I read also circumvent a number of analytes that is
necessary to justify the usage of the term metabolomics. Evans et
al. probably give the gist of the matter by saying that metabolomics
should aim at a greater understanding of the perturbation-prone pro-
cesses investigated [23].
In fact, following these definitions studying human aging metab-
olome refers to ‘metabonomics’, but as the term ‘metabolomics’ has
become much more prominent in literature and also a substitute of
‘metabonomics’ or a general term for both, ‘metabolomics’ is used here.
One could also argue that the present thesis deals with age but not
with aging as it employs a cross-sectional population study (details
in 2.1.1) and thus is metabolomics.
Some additional definitions are helpful in the metabolomics field.
The numerous metabolites measured are referred as small molecules metabolite,
metabolomewith a molecular weight below 1500 Dalton [1] and can be both en-
dogenous and exogenous, intermediate and end products of biochem-
ical pathways. They ideally represent the whole range of intermediate
metabolic pathways, and may serve as biomarkers indicating distinct
physiological or pathophysiological states of an organism. Metabo-
lomics is therefore a valuable tool to investigate all these influences
on the metabolism together in one approach and link them to the
phenotypic outcome of interest. Metabolites in their entirety in a
specimen are named metabolome according to the established terms
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genome, transcriptome, and proteome (appendant to the methods of
genomics, transcriptomics, and proteomics, respectively). However,
the aim of analyzing the whole metabolome is ambitious as numbers
from Human Metabolome Database (HMDB) show. The HMDB, a freely
accessible collection of vast metabolic information, records 40,278 me-
tabolites identified from human organism11, of which 20,146 from
blood ([91, 36] HMDB version 3.0, Jan 2013).
Metabolites have various tasks and particularly fulfill critical roles
in an organism as they are involved in energetic processes, regulation
of enzyme activities, structure build-up, and signaling [84]. Notably,
metabolites are not coded in the genome, but products of metabolism,
which, in turn, is the whole of biochemical pathways of the cells. Con-
centrations of metabolites are functional end points of metabolic path-
ways and reflect individual affectors like nutrition, physical activity,
and medication [88].
1.2.2 Technical aspects
Metabolomics is described as a technique easy to measure compared
to other omics [45]. After preparation of the sample the general an-
alytical steps are separation and identification of the compounds of
interest. Two main methods for identification are in use: NMR and MS.
NMR spectroscopy applies as basic principle of identification the spe-
cific pattern in the chemical shift of specific atoms12 [75]. MS-methods
are based on an initial ion formation —various methods of ionization
exist— followed by ion separation according to the mass-charge ra-
tio resulting in the measurement of the specific molecular mass of a
metabolite and, if a tandem mass spectrometry is used, also on the
specific fractionation pattern of the molecule. If combined with liq-
uid chromatography (LC) or gas chromatography (GC) for separation
(so-called hyphenated methods), retention time is another parameter
of characterization [75]. The actual identification of the compounds is
done by computer programs after the experiments. MS-based meth-
ods are assigned to have higher sensitivity than NMR-based ones but
need more extensive sample preparation and measurement proce-
dure, which is accompanied by higher risk of experimental errors
[75]. MS needs metabolites to be extracted from the samples and thus
destroys the sample whereas NMR employs the sample as a whole
11 According to the release note for version 3.0, there are now both detected and ex-
pected metabolites included in the database. However, the number of detected is
20,911.
12 Molecules with spin in a strong magnetic field can accept energy and thus generate
local magnetic fields, which are dependent on local electronic and magnetic environ-
ment in the molecule. The resonance frequency applied to the molecule shifts the
frequency of the nucleus in dependence of the local surroundings, i. e., the chemical
shift which can then be measured. As 12C and 16O do not have spin, 1H is well
suitable for identification of diverse metabolites. [47]
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Figure 3: Analytical performance of NMR and MS.
Comparison of metabolomics methods: hydrophilic properties and
concentration range of the metabolites differ between the methods
[3].
and leaves it intact for further use. Furthermore, the number of refer-
ence samples differs considerably between the methods: one to two
for NMR but almost as many references as metabolites measured for
MS. Reproducibility is clearly higher for NMR than for MS. Figure 3 dis-
plays analytical differences of NMR and MS depending on metabolite
properties.
The technical section should be finished with a few general remarks
about the application of metabolomics. Concerning the comparability
of metabolomics studies, it should be noted that small differences in
the experimental assembly may induce significant effects on the ana-
lytical results. The biochemical identification of the metabolites turns
out to be still the bottleneck as many of them remain unidentified
[75]. Particularly, the vast differences in chemical properties of the
metabolites challenge the measurement methods [84].
The experimental setup used in the Cooperative Health Research Biocrates Abso-
luteIDQ™p150
kit
in the Region of Augsburg (KORA) study comprises an additional
metabolomic setup: an assay kit was applied that comes with spe-
cially designed plates, all standards and quality control samples as
well as software for managing the workflow and concentration calcu-
lation (Biocrates AbsoluteIDQ™13 p150 together with MetIDQ soft-
ware). This kit was designed to target 163 common metabolites in
human samples, i. e., a wide range of lipid species (PCs, lyso phos-
phatidylcholines (lyso PCs), SMs, and acylcarnitines (ACs)) complement-
ed by the sum of hexoses (H1) and AAs (see table 1). The focus on
lipids also suits well to the topic of aging as these metabolites were
assigned to play a key role in the process by many studies [93]. Ma-
13 IDQ stands for identification and quantification
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Table 1: Metabolite classes in the Biocrates kit, adapted from Biocrates prod-
uct information sheet and [95]
metabolite class N biological relevance (examples)
acylcarnitines 41 energy metabolism, fa transport, β-
oxidation, oxidative stress
amino acids 14 AA metabolism, urea cycle, insulin sensitivi-
ty/resistance
sum of hexosess 01 carbohydrate metabolism
phosphatidylcholines 77 membrane composition and damage, fa pro-
file, activity of desaturases
lyso phosphatidylcholines 15 phospholipase activity, membrane damage,
fa profile
sphingomyelins 15 signaling cascades, membrane damage
chine facility used in this study was a FIA-MS/MS. The methods section
expatiates on experimental details (2.1).
A major disadvantage of the Biocrates kit is the lack of exact de-
termination of side chains in PCs and SMs, only empirical formulas
denominating the number of C atoms and sum of double bonds are
determined but length of each side chain with its exact positions of
the double bonds is not available. More information on the identified
compounds is given in chapter 2.1.2
1.2.3 Challenges of metabolomics
For investigation of complex diseases/traits with multiple determin-
ing parameters in one approach, metabolomics is a well-suited tool
that provides more robust data than mono-parametric approaches
by reduction of false-positive results and is also more cost-effective
[88]. It is already used routinely in newborn screenings for inborn
errors of metabolism. Despite all the praise for it, metabolomics also
holds many challenges. Metabolomics platforms shall produce data
with low variability, detect still small concentrations of a metabolite,
distinguish molecules with similar chemical properties and at the
same time capture the whole range of very different molecules of
the metabolome [23]. The researcher has to find ways to handle the
huge data-sets generated by metabolomics experiments, to deal with
multiple testing and with correlations between metabolites as they
are interlinked by biochemical reactions in metabolic networks [75].
Thereupon, complex results need to be displayed in a clear and plain
manner and at last to be interpreted. Interpretation requires man-
ual integration of biochemical information from databases like HMDB
and the Kyoto Encyclopedia of Genes and Genomes (KEGG) which en-
counters limits when it comes to less known or unknown metabolites.
Furthermore, one has to take into account the influence on metabo-
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lite concentrations of parameters like sampling time14, fasting status,
co-morbidity, physical activity, diet, gender.
Attention needs to be drawn to the fact that altered levels of a
metabolite can derive from both anabolic and catabolic processes [46].
Lawton and co-authors give the example of 3-methylhistidine whose
blood levels can correspond to a high protein diet or to an acute
increase in protein breakdown. Constant levels however may point to
adaptive processes in other functions like expression and function of
a related transporter.
1.3 metabolomics studies on aging
For capturing the complexity of the aging process in a large cohort
study, metabolomics is a very promising tool and according to Par-
tridge et al. in 2011 [61], systemic approaches into aging have just
begun. Following genomics, transcriptomics, and proteomics in ag-
ing research, metabolomics is assigned to deliver information about
several tissues at once concerning their short-term regulation [45].
As described by Kristal and Shurubor in 2005 [45], genomics helped
identifying potential genes involved in longevity and age-associated
diseases, but does not help understanding the aging process better15.
Transcriptomics reveals translational changes of the genome with older
age, but is limited to single tissues and gives no insight into post-
translational processes. Proteomics could give some insight into post-
translational products and into accumulated proteins, a common age-
phenomenon, however, its limits are short-term regulation and an-
alytical challenges with serum samples. Metabolomics seems to be
the logical next step in the aging field. The article also raises sev-
eral questions that metabolomics may answer uniquely; two of them
of interest for this thesis: Is there a qualitative or quantitative effect
of aging to the metabolism and will metabolomics help identifying
biomarkers of aging? A more integral and comprehensive approach
to the complexity of aging that includes dynamics of metabolic net-
works combined with genomic networks is also claimed by West and
Berman [89]. Soltow et al. even name metabolomic changes the best
representation of age-associated declines of function [73] and point
out that an overall process like aging requires a systems approach
as the traits studies so far as stand-alone are likely to be involved
together.
To my best knowledge, only few aging studies with metabolomics
analyses have been conducted in animal models yet. There are very
few published results from human adult studies that concentrate on
aging so far, derived from low participant numbers [46]. Orešicˇ men-
14 Many metabolites are know to be subjects of circadian rhythm [49].
15 Which fits well to the Hayflick theory in section 1.1.2 that genetics do not play a role
in aging.
14 introduction
tioned that human metabolome has been shown to be sensitive to age
[59], but the given references for that review supply only one compa-
rable publication. Nikkilä and colleagues performed a metabolomics
study in early childhood with 59 children followed up from birth
to an age of four years and identified previously unknown metabolic
changes with age [56]. A study of 269 individuals of both male and fe-
male gender analyzed the human plasma metabolome, but with NMR
technique and thus a very different set of metabolites than used for
this thesis [46]. Nevertheless, comparing the 3 age groups revealed
more than 100 metabolites associated with age, some associations
were sex affected, but no race effects were found. Most concentra-
tions were highest in the oldest group compared to the youngest
group (unless indicated otherwise): From AA metabolism there were
serine, alanine, glutamine, glycine, glutamate, histidine, isoleucine,
valine, leucine, lysine, hippurate, p-cresolsulfate16, 3-methylhistidine,
ornithine. From carbohydrate, lipid, and energy metabolism myo-
inositol, lactate, mannose (lower), a number of fa, β-hydroxybutyrate,
cholesterol, DHEA-sulfate (lower) showed up, and furthermore citric
acid intermediates and metabolites associated with nucleotide metab-
olism were identified. The latter study illustrates two main challenges
occurring with metabolomics in epidemiological context. Number of
subjects is often very low compared to the high number of variables
that comes along with metabolomics analyses and that is often even
split up into groups (e. g., age, sex). Comparability is another prob-
lem, because of different platforms as discussed in 1.2.3 and also dif-
ferent sample sources (e. g., serum, urine).
An overview of studies on aging with help of metabolomics tech-
niques is given in tables 2 and 3. For this, a Pubmed search with “me-
tabolomics and age” was done, similar searches did not yield more re-
sults (using terms like metabonomics, metabolic profile, aging). Only
studies more or less “pure” into age/aging were included, however,
some with an additional intervention group related to the aging field,
e. g., CR, but studies on age-related diseases were excluded.
16 p-cresol sulfate is a microbial metabolite that is found in urine and likely derives
from secondary metabolism of p-cresol. from HMDB entry HMDB11635; p-cresol (4-
methylphenol) is an end-product of protein breakdown. HMDB01858























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Comments for tables 2 and 3
notes
1’n’ refers to the number of subjects given in the table refers to the n used for
metabolomics analyses, not necessarily equals the whole study group.
2m. . . male, f. . . female
3d. . . days, w. . . weeks, mo. . . months, y. . . years
4Same metabolomics method does not necessarily mean that it was the same ex-
perimental procedures as there are lots of parameters that can vary. For the purpose
here, it was simplified to NMR (which was in all listed studies 1H NMR) and LC-MS
(which often was combined with a second MS measurement and predominantly was
hplc-MS).
5(un-)targeted; in brackets no. of compounds identified
18 NOTES
1.4 hypotheses and aims of the thesis
Many papers on aging investigate special details of aging processes.
However, I applied a novel method to capture more of the complexity
of the matter. The aim was to characterize the metabolic profile of a
large and healthy group of subjects from KORA with a wide age range
(n=1038, 32–81 years) to provide a first solid basis for further metab-
olomics studies and for further studies on age-related diseases with
metabolomics technology and prolongation of the phase of healthy
aging. It was also sought to possibly connect the age-associated pro-
file to some extent to common aging theories as the oxidative damage
in mitochondria or aging phenomena as vascular lesions and altered
cell functions to better understand aging process with regard to the
metabolism.
2
M AT E R I A L S A N D M E T H O D S
2.1 experimental procedures
2.1.1 Population Source
Cooperative Health Research in the Region of Augsburg (KORA) is a
population-based research platform with subsequent follow-up stud-
ies in the fields of epidemiology, health economics and health care
research [67]. It is based on interviews in combination with medical
and laboratory examinations, as well as the collection of biological
samples. Four surveys were conducted with 18,079 participants liv-
ing in the city of Augsburg and 16 surrounding towns and villages.
KORA Survey 4 (KORA S4) consists of representative samples from
4261 individuals. The dataset comprises individuals aged 25–74 years
resident in the region of Augsburg, Southern Germany, examined in
1999–2001. During the years 2006–2008, 3,080 participants took part
in a follow-up (KORA F4) survey of the one conducted 7 years ago.
For the purpose, a total of 918 subjects from KORA F4 were excluded
for subsequent analyses resulting in a number of 2,401 subjects aged
32–81 years. Among the excluded were 20 experimental failures, 18
non-fasting subjects, 332 type 2 diabetics, 80 subjects without fasting
glucose or 2h glucose measurement, 77 subjects with systolic blood
pressure >160 mmHg, and 153 subjects with BMI > 35kg/m2. Further
removals followed during statistical analyses (n=239, see section 2.2).
2.1.2 Sampling and metabolite measurements
Blood was drawn into serum gel tubes in the morning between 8:00
and 10:30 a.m. after a fasting period of at least 8 hours and the tubes
were gently shaken on a horizontal shaker for 5 minutes, followed by
30 minutes resting at room temperature to obtain complete coagula-
tion. For serum collection, centrifugation of blood was performed at
2750 g and 15 °C for 10 minutes. Serum was frozen at −80 °C until
execution of metabolic analyses.
The targeted metabolomics approach was based on measurements
with the AbsoluteIDQ™p150 kit (BIOCRATES Life Sciences AG, Inns-
bruck, Austria) allowing simultaneous quantification of 163 metabo-
lites. The method has been proven to be in conformance with FDA-
Guidelines “Guidance for Industry - Bioanalytical Method Validation
(May 2001)”, which implies proof of reproducibility within a given
error range. All liquid handling was done with a Hamilton Star robot
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(Hamilton Bonaduz AG, Switzerland), 100 µl serum sample were
used per participant. Technical equipment for metabolite measure-
ments was an API 4000 Q TRAP LC-MS/MS System (Applied Biosys-
tems) equipped with a Schimadzu Prominence LC20AD pump and
a SIL-20AC autosampler applying multiple reaction monitoring, neu-
tral loss and precursor-ion scans. Internal standard served as refer-
ences for quantification. The MetIQ software of the AbsoluteIDQ kit
was applied to supervise the whole analytical process.
All metabolite concentrations are reported in micromolar (µM). Some
more background on the method is given in the introduction (section
1.2.2) and analytical details have been published in [38].
The Biocrates kit quantifies 14 AAs, H1, 41 ACs including free carni-
tine, 15 SMs, 77 PCs and 15 lyso PCs. Additional chemical groups that
can be identified are hydroxyl groups denoted by OH and dicarboxyl
groups denoted by DC. Lipid side chain composition is abbreviated
as Cx:y, where x stands for the number of carbons in the side chain(s)
and y the number of double bonds. Chemical bonds are indicated
as aa for diacyl and ae for acyl-alkyl bonds. Full biochemical names
with their respective short form are listed in table 9 on page 54ff.
As already discussed in section1.2.2, exact conformations in terms
of length of the side chains and distribution and position of double
bonds cannot be distinguished with this experimental setup. Alterna-
tive metabolite names are given for cases of e. g., stereoisomeres and
isobaric fragments that are not discernible.
A substantial part of the metabolites determined by the Biocrates
kit shows values below limit of detection (LOD) or coefficient of varia-
tion (CV) close to 25% [38]. However, it is important to measure those
as well, as their concentrations may increase drastically in disease or
upon environmental challenge [59]. These metabolites could repre-
sent a valid trend to be evaluated in more detail. Metabolite measure-
ments for the 3080 samples were performed in three batches, with two
and three months time lapse in between, respectively. Within each kit,
there are three different quality controls (QCs) provided by the man-
ufacturer and representing mixed human plasma samples. In accor-
dance with the kit instructions, concentration of each metabolite was
adjusted based on the three QCs to minimize potential batch effects.
To ensure data quality, each metabolite had to meet three criteria:
1. Average value of the CV for the metabolite in the three QCs
should be smaller than 25
2. 90% of all measured sample concentrations for the metabolite
should be above the LOD.
3. The correlation coefficient between two duplicate measurements
of the metabolite in 144 re-measured samples should be above
0.5.
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In total, 131 metabolites passed the three quality control steps, and
the final metabolomics dataset contained the H1, 14 AAs, 24 ACs, 13
SMs, 34 diacyl phosphatidylcholine (PC aa), 37 acyl-alkyl phosphatidyl-
choline (PC ae) and 8 lyso PCs. Table S1 in the appendix summarizes QC




For the detection of outliers, concentrations obtained for the remain-
ing 131 metabolites were first scaled to have a mean of zero and a stan-
dard deviation (SD) of one, and were projected onto the unit sphere;
Mahalanobis distances for each individual were then calculated using
the Robust principal components algorithm [26]. Calculations were
done separately for males and females. For each group, the mean
Mahalanobis distance plus three times variance were defined as cut-
off. 239 individuals, whose distances were greater than these cut offs,
were identified as outliers and removed subsequently.
2.2.2 Clustering and heat map
For participants with the same age, mean values were calculated for
the concentrations of each metabolite. Spearman correlation coeffi-
cients were computed to determine the distances matrix of ages for
clustering purpose. A dendrogram was generated based on hierarchi-
cal clustering algorithm using average agglomeration method. Stan-
dardized metabolite concentrations were used to draw a heat map
showing the changes of the metabolite concentrations with the in-
crease of age; the color change in the heat map represents the concen-
tration deviation from the mean value. R-packages bioDist and gplot
were used.
2.2.3 Linear and logistic regression analyses
Linear regression was applied to model the relationship between age
and the concentration of each metabolite with BMI used as covariate.
Metabolite concentrations were log-normalized. The regressions were
done for males and females separately. Smoother plots were drawn
for each metabolite of the set of metabolites with the R function ‘qplot’
(package ‘ggplot2’) using the options geom=smooth, method=loess,
span=0.5 producing smoother plots with locally weighted regression
(locally weighted scatterplot smoothing (loess)) applying a smoothing
span of 0.5, which results in medium smoothing. loess computes out-
lier robust locally weighted regression fitted values by fitting local
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polynomials using the weights and results in the loess curve as shown
in our smoother plots. Further information about the method is avail-
able in ref. [14]. For better visualization the plots were truncated to
observations between first and 99th percentile. The odds ratio (OR) for
single metabolites were calculated between two groups with normal-
ized metabolite concentrations and BMI as covariate. The obtained OR
value stands for whether the probability of an increase in metabolite
concentration of one SD was the same for both age groups. To han-
dle false discovery rate from multiple comparisons, the cut point for
significance was calculated according to Bonferroni revealing a signif-
icance level of 3.8E-4 (correcting for 131 metabolites).
2.2.4 Criteria for metabolite selection
Multivariate logistic regression, random forest, and a stepwise selec-
tion of logistic regression methods were applied: The metabolites
were chosen if they were significant in both logistic regression for
single metabolite with adjustment for BMI and also in the top 30 most
important variables obtained using the random forest method, where
the 131 metabolites and BMI were included as variables. The resulting
set of metabolites was further reduced through a stepwise variable
selection approach using the Akaike information criterion (AIC) as cri-
terion and with BMI as covariate. This selection procedure resulted in
sets of metabolites thought to characterize age in females and males,
respectively.
All calculations were done with the R statistical platform, version
2.12 [66].
2.3 replication and meta-analysis
TwinsUK is a UK-wide twin registry sample of 11,000 adults founded
in 1993 with the aim to explore the genetic epidemiology of common
adult diseases [74]. The cohort has been tested to be generalizable
to UK population singletons with no population stratification for a
wide variety of musculoskeletal, CVD, and metabolic traits [2]. Over
7,000 twins have attended detailed clinical examinations with a wide
range of phenotypes over last 18 years. Blood samples were taken
after at least 6 hours fasting at each visit. The samples were immedi-
ately inverted three times, followed by 40 minutes resting at 4°C to
obtain complete coagulation. The samples were then centrifuged for
10 minutes at 3,000 revolutions per minute. Serum was removed from
the centrifuged brown-topped tubes as the top, yellow, clear layer of
liquid. Aliquot in 4x1.5mls skirted micro-centrifuge tubes was then
stored in a −45°C freezer until sampling. 1,237 twins were selected
for the targeted metabolomics profiling for either osteoarthritis or ge-
netic studies. Metabolite measurements were performed using the
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same metabolomics platform and following an identical protocol as
for the KORA study. For the purpose of the replication for the KORA F4
study, the data on the 12 age-related metabolites identified in the
KORA F4 aging study were retrieved, and the association between age
and these 12 serum metabolites were analyzed by robust regression
modeling which takes into account of twin relatedness. A total of
1,237 individual with metabolomics data were available, among them,
44 males were excluded. Following KORA’s exclusion criteria, 64 indi-
viduals with systolic blood pressure >160mmHg, 14 individuals with
type 2 diabetes, 45 individuals with BMI >35 kg/m2, and 328 indi-
viduals without either blood pressure, fasting serum glucose levels,
or diabetes diagnosis data available were excluded . A total of 742
healthy female individuals were included in the final analysis. For




R E S U LT S
3.1 study population
The KORA F4 study sample comprised 1,038 females and 1,124 males
with a wide age range of 32–81 years. Females and males of the
KORA F4 study have about the same average age, but females exhibit
a larger average BMI than males (1.2 kg/m2 difference). Comparing
KORA females with the replication sample from TwinsUK, KORA fe-
males have a lower mean age than TwinsUK females (4.1 years dif-
ference) and an overall somewhat smaller age range. The BMI of the
females in KORA is 1.5 kg/m2 larger on average than in the females
in the TwinsUK. As expected, BMI was significantly correlated with
age in KORA F4 (Pearson’s ρ=0.26, p=2.2E-16). Serum concentrations
of 163 metabolites were measured in all participants. A total number
of 131 metabolites passed the quality criteria levels (see chapter 2)
and entered the subsequent statistical analyses. The final set of 131
metabolites with full nomenclature is summarized in table 9 in the
appendix1. Characteristics of both the discovery and replication pop-
ulation are depicted in table 4.
3.2 discovery of age discriminating metabolites – gen-
eral procedure
Due to prior results from KORA F4 showing strong metabolic differ-
ences between females and males [52], I conducted strictly sex-separat-
ed analyses. Two different approaches were applied in parallel to un-
ravel the associations between metabolites and age. On the one hand
continuous analyses were conducive to characterize age-associated
changes regarding metabolite concentrations using linear regression
1 The table also includes those metabolites which failed the quality control.
Table 4: Population characteristics of KORA F4, subdivided by gender, and
TwinsUK. Values given as mean ± SD.
KORA F4 TwinsUK
Males Females Females
n 1124 1038 742
Age (years) 53.6 ± 12.5 54.1 ± 13.1 57.7 ± 10.6
BMI (kg/m2) 25.9 ± 3.9 27.1 ± 3.2 25.6 ± 3.7
25
26 results
Table 5: Top ten of BMI-adjusted linear regression between age and log of
metabolite concentrations in KORA F4 females; ? below significance
level
metabolite estimate SE p-value
C12:1 0.009 0.001 1.58E-40 ?
C10:1 0.01 0.001 2.70E-37 ?
PC ae C36:1 0.007 0.001 3.76E-37 ?
C18 0.008 0.001 1.21E-36 ?
C16:2 0.01 0.001 2.06E-35 ?
PC aa C28:1 0.007 0.001 3.83E-33 ?
C18:1 0.007 0.001 4.24E-33 ?
C16:1 0.007 0.001 1.78E-32 ?
C16 0.006 0.001 1.42E-29 ?
C14:1-OH 0.007 0.001 2.78E-29 ?
models, smoother plots and heat maps. On the other hand cluster
analysis for age led to an approach of group comparison with two
groups (32 – 51 years versus 52 – 77 years) and helped to identify a
set of 12 markers differentiating age in women. As a combination of
both analytical approaches, most illustrations were restricted to these
12 markers.
3.2.1 Characterization of Age-Metabolite Associations
An initial, BMI-adjusted linear regression analysis between metabolite
concentrations (logarihtmized for normality) and age revealed first
indications for strong associations as a number of 73 metabolites in
women (top ten shown in table 5, full table in the appendix, table 10,
page 62) and of 39 metabolites in men (top ten shown in table 6, full
table in the appendix, table 11, page 64) reached significance level of
10−7. Subsequent analyses were conducted to unravel details.
In order to broaden the initial results from linear regressions, a
cluster analysis for the 131 metabolites was done across all ages sep-
arately for females and males. The resulting heat map for females dis-
plays metabolites with a clear decrease over age, in particular with
most acylcarnitines (ACs), others showed a gradual increase with age,
e. g., several PCs (Figure 4). Major metabolite groups are represented
by gray boxes in the figure.
Details on the abbreviated metabolites names are listed in table 9
(see appendix, page 54), which also contains mean concentration, SD
and ranges for all 131 metabolites for both females and males. The
heat map for males did not show such strong and consistent changes
and clusters (see appendix figure 7, 48), therefore I concentrated on
3.2 discovery of age discriminating metabolites – general procedure 27



































































































































































Figure 4: Heat map of KORA F4 females.
The heat map shows changes of fold standard deviation from the
overall mean concentration for each year in a color-coded way, and
clustering of these changes. Green squares represent a decrease,
and red squares an increase. Gray boxes represent groups of meta-
bolites with similar changes with number of metabolites in paren-
theses. Metabolite names in red indicate the set of 12 metabolites
(see 3.2.2). amino acid (AA); acylcarnitine (AC); diacyl phosphati-
dylcholine (PC aa); acyl-alkyl phosphatidylcholine (PC ae); and lyso
phosphatidylcholine acyl (lyso PC a).
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Table 6: Top ten of BMI-adjusted linear regression between age and log of me-
tabolite concentration in KORA F4 males; ? below significance level
metabolite estimate SE p-value
Trp -0.003 2.78E-04 3.67E-33 ?
Val -0.005 4.00E-04 6.61E-31 ?
C16:1 0.007 0.001 1.60E-26 ?
His -0.004 3.36E-04 2.67E-26 ?
C12 0.008 0.001 3.50E-26 ?
C16:2 0.009 0.001 3.65E-26 ?
xLeu -0.004 4.03E-04 7.83E-25 ?
lysoPC a C20:3 -0.006 0.001 4.54E-22 ?
C18:1 0.006 0.001 3.09E-20 ?
C10:1 0.007 0.001 2.38E-19 ?
females in all subsequent analyses. Nonetheless, results for males are
provided in the appendix.
Smoother plots were drawn to characterize the trends and courses of
metabolite concentration changes with age in females (figure 5) (see
figure 8 for females from the TwinsUK study (replication sample) on
page 49, figure 9 for males on page 50 in the appendix). The smooth-
ing method was loess, which is a locally weighted regression robust
against a small fraction of outliers. As already stated for the heat
map, some metabolite concentrations showed increasing, and some
showed decreasing trends with age, but smoother plots provide a
deeper insight. Concentrating on the 12 markers identified in females
in steps described in section 3.2.2, the larger proportion of metabo-
lites showed clear linear associations or proximate linear trends with
age (C12:1, C18:1, His, Orn, PC aa C28:1, PC ae C36:1, SM C18:1, SM
C16:1). The remaining four metabolites (PC ae C42:4, PC ae 42:5, PC
ae C44:4, PC ae 44:5) exhibited a decrease around age of 51 with ap-
proximate constancy prior and after this age period.
3.2.2 Identification of a discriminating metabolite set for age in females:
comparison of two age groups 32 – 51 vs. 52 – 77 yrs.
Vertical patterns in the heat map of females and curve shapes in four
of the smoother plots (PC ae C42:4, PC ae C42:5, PC ae C44:4, PC ae
C44:5) prefigured a point of inflexion for age around 50 years. Sub-
sequent cluster analysis for age revealed that all females of 51 years
and younger grouped together due to their metabolite concentrations
of the 131 metabolites and the subjects from age 52 to age 77 ar-
ranged together as well (figure 10 on page 51). A third group was
formed by the 78 to 81 years old subjects, but because of its low per-




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































40 50 60 70 80
Figure 5: Smoother plots for 12 markers in females.
The plots show concentration trends of the 12 identified markers
across age in KORA F4females with age on the x-axis and concentra-
tion on the y-axis, respectively.
30 results
son number (n=41) this group was excluded from further analyses.
As consequence, two groups were used for the subsequent identifi-
cation of metabolites differing in both groups: 32 – 51 years versus
52 – 77 years. Applying several statistical methods (see chapter 2), 12
metabolites could be denominated that clearly differed in their con-
centration between females up to an age of 51 and females above 51.
These potential markers behaved differently between the two groups
as some showed higher and some lower levels with higher age. Table
7 (page 31) shows the set of markers with the corresponding param-
eters from the linear analysis. In males 15 significantly changing me-
tabolites could be identified as differentiating markers over the age
groups (table 8 on page 34), only 3 of them were similar to females’
markers (His, C12:1 and C18:1), but overall the associations between
metabolites and age were not as strong as in females (i. e., higher
p-values in general).







































































































































































































































































































































































































































































































































































































































































































































































3.3 replication of the metabolite set and meta-analysis
For replication purpose, I got support from the TwinsUK cohort with
an independent sample of 742 healthy female subjects with metabo-
lomics data available. The metabolites showed comparable mean con-
centrations in both studies. Among the 12 age-related metabolites
found in the KORA study, 10 metabolites were well replicated in the
TwinsUK sample with all p<0.004 which was the significance level after
adjustment for multiple testing with Bonferroni method (α of 0.05/12
metabolites=0.004) (Table 7), and the effect direction was the same as
in the discovery sample except for one metabolite, PC ae C36:1, with
borderline significance in the TwinsUK sample (p=0.002). When the
sample was divided into two groups (people with age 6 51 and peo-
ple with >51 as in the KORA study, data not shown), 8 metabolites
replicated. I also draw the smoother plots for the TwinsUK sample and
obtained similar curve shapes for all but PC ae C36:1 (Figure 8 in
the appendix, page 49). Furthermore, both study samples were ana-
lyzed in a meta-analysis which gave similar results as in the KORA
females sample alone (i. e., virtually the same magnitudes of beta es-
timates and p-values). All 12 metabolites of the marker set reached
significance with p-values range from 2.28E-09 to 4.02E-40.
3.4 further approaches
Some further methods were applied to unravel the nature of age-
metabolite associations. As from earlier publications [87, 95, 38, 29],
ratios of metabolite levels can provide hints to enzyme activities af-
fected in the outcome of interest. If the ratio consists of an enzymatic
product-substrate pair, it may proxy for the reaction rate of the ap-
pendant enzyme. Gieger et al. found the ratio [PC aa C36:4]/[PC aa
C36:3], product/substrate pair of the delta-5 desaturation, to be a
strong proxy for the fatty acid desaturase 1 (FADS1) activity [29]. Use
of metabolite ratios reduces the variance and renders statistically ro-
bust results [38]. In my analysis, no such hints for altered enzyme
activities could be found as only ratios of metabolites not directly
linked by an enzyme in biochemical pathways were significantly as-
sociated with age (i. e., , no product-substrate pairs). It seems, that no
pair out of 131 metabolites analyzed in KORA F4 is significantly linked
by an age-associated enzyme.
A promising tool for understanding relationship between metabo-
lites associated with age is the genetic network analysis with help
of the databases GenAge Database of Ageing-Related Genes (GenAge)
[19] and Search Tool for the Retrieval of Interacting Genes/Proteins
(STRING) [39]. The resulting network contained only links not with-
standing a deeper check of real association (i. e., many links were cre-
ated only on simultaneous occurrence of these metabolites anywhere
3.4 further approaches 33
in a publication, but no actual known association). The failure of this
approach may be due to a lack of research results in aging concerning
the metabolites from the metabolomics kit used in KORA as many of
these were not included in databases at that time (in particular, the
lipid species). Another explanation follows up the Hayflick definition
of aging from section 1.1.2. Hayflick states that the genomes does not
contain instructions for the organism to age [32] and thus, networking
on the basis of genes cannot work for this study.
34 results
Table 8: Potential biomarkers for age in KORA F4 males. Mean concentration
in µM from serum; beta estimates represent changes per year of age,
adjusted for BMI; ? below significance level
KORA F4 Males
marker mean ± SD beta (SE) p-value
C10:1 0.15 ± 0.05 53.66 (6.12) 7.62E-18 ?
C12:1 0.14 ± 0.04 73.10 (6.97) 1.63E-24 ?
C16:1 0.04 ± 0.01 389.31 (35.98) 6.26E-26 ?
C18:1 0.12 ± 0.03 92.61 (10.15) 3.67E-19 ?
Gln 603.76 ± 89.22 -0.03 (0.00) 5.87E-13 ?
His 97.29 ± 13.72 -0.29 (0.03) 6.15E-26 ?
Trp 80.23 ± 8.87 -0.46 (0.04) 3.67E-33 ?
Val 247.58 ± 43.66 -0.09 (0.01) 8.48E-31 ?
lyso PC a C18:2 25.86 ± 8.33 -0.36 (0.04) 3.69E-18 ?
lyso PC a C20:3 2.22 ± 0.61 -5.07 (0.55) 1.36E-19 ?
PC aa C32:0 15.10 ± 3.00 0.71 (0.13) 8.03E-08 ?
PC ae C30:2 0.17 ± 0.04 -32.6 (11.44) 0.004
PC ae C36:1 8.96 ± 2.06 1.53 (0.24) 1.56E-10 ?
PC ae C42:0 0.52 ± 0.10 29.29 (4.05) 9.05E-13 ?
SM C20:2 0.43 ± 0.11 -7.97 (4.60) 0.084
notes
1’n’ refers to the number of subjects given in the table refers to the n used for
metabolomics analyses, not necessarily equals the whole study group.
2m. . . male, f. . . female
3d. . . days, w. . . weeks, mo. . . months, y. . . years
4Same metabolomics method does not necessarily mean that it was the same ex-
perimental procedures as there are lots of parameters that can vary. For the purpose
here, it was simplified to NMR (which was in all listed studies 1H NMR) and LC-MS
(which often was combined with a second MS measurement and predominantly was
hplc-MS).
5(un-)targeted; in brackets no. of compounds identified
4
D I S C U S S I O N
4.1 general aspects
In this thesis, I present strong associations between age and the hu-
man metabolome and identified 12 metabolites from a metabolomics
screen of 1,038 healthy women with potential to serve as a set of age
differentiating markers in women. These results from the KORA study
could be replicated for 10 out of the 12 markers in 742 women partic-
ipating in the TwinsUK study. Findings in males were less definite, but
also led as well to the identification of an age-discriminating set of
15 metabolites1. I consider these results as helpful for understanding
the metabolic alterations during aging in more detail.
The extent of sexual dimorphism regarding the metabolome has al- Gender differences
ready been shown in a recent paper by Mittelstrass et al. [52]. Hence,
analyzing the study group in a sex stratified manner was a corollary.
The cause of less significance of results from the male stratus was un-
knowable, I think of lifestyle issues and different life experiences as
prominent. Nonetheless, three metabolites showed up in both in fe-
males and males thus considered as potential age differentiating me-
tabolites without gender influence (i. e., C12:1, His, and PC ae C36:1).




ways, whose alteration might have led to the observed changes in me-
tabolite concentrations and might additionally link the observations
to common aging theories. However, greatest part of the cited results
stems from animal models, which requires a further comment about
comparability. Fontana et al. particularly emphasized the evolution-
ary conservation of anti-aging pathways in terms of composition and
function across different species from yeast over mice to humans [27].
Notably, nutrient-sensing pathways seem to play important roles in
aging in many species. Another publication describes three major age-
regulating processes as evolutionary conserved between human and
mice [24], i. e., the immune system, epigenetics, and aerobic metabo-
lism, which also plays a major role in this discussion (see paragraph
on ACs below).
As apparently diseased participants had been excluded2, I assume
that the study population has aged largely healthy so far and thus
exhibits the regular mechanisms to combat aging issues like the oc-
currence of oxidative stress and impaired neuroendocrine-immune
1 Results from males are, again, not the main object of interest here and thus, not
discussed in detail.
2 I further assume that heavily ill persons do not participate in a study at all.
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functions (also termed as successful aging [60, 4]). Overall, I consider
that the metabolites of the marker set tag for alterations in parts or
their whole substance class with age.
In general, the concentration courses illustrated in smoother plots
deviate from my expectation, insofar as I hadn’t anticipated to see
both almost strait lines and curves with clear inflection points. One
might argue that the sudden changes are related to hormonal changes
in women, but several male metabolites also showed inflections (see
appendix figure 9 on page 50). Reasons thus might derive from the
cross-sectional design or any factors not measured. Heat maps also
didn’t show the expected hints to groups of metabolites that change
conversely and might have indicated links to affected enzymes or
pathways3. Instead, clusters in the heat map were a smorgasbord of
metabolite classes (shown as gray boxes in figure 4 on page 27 and
in appendix figure 7 on page 48). This might reflect the complexity of
aging with pathways not affected in isolation but in a greater system.
Following up the state of knowledge on aging metabolism as sum-
marized in section 1.1.3, my results clearly support the observations
on altered lipids as I found different lipid classes to be affected: ACs,
PCs, and SMs. Particularly the ACs are thought to reflect changes in
ffas as seen in [80] and provide a link to the aging theory of mito-
chondrial dysfunction (discussed in more detail below). However, a
comparison is difficult as my analysis is based on a much deeper look
on distinct lipid species than the cited studies, which offers a much
more detailed interpretation. In the following paragraphs, I discuss
the metabolites on their substance class level with regard to aging
mechanisms.
4.2 metabolite classes
Phospholipids are major components of cell membranes. It is knownphosphatidylcholines
(PCs) that enzyme activities of the deacetylation-acetylation cycle in the
glycerophospholipid metabolism change with age. This is underlined
by the findings of DeGuzman et al. of decreased levels of lyso PCs 16:1
and 18:4 in aged mice [18]. The cycle helps adjusting and regulating
membrane fluidity via the fatty acid composition of phospholipids
in cell membranes. A high unsaturation degree of membrane phos-
pholipids of old rats has been observed. Highly unsaturated fas are
especially prone to lipid peroxidation, which commonly occurs with
higher age. Products contribute to low-grade inflammation. Interest-
ingly, long-lived animals indeed show low degrees of unsaturated
membrane fas compared to short-lived ones. Besides deacetylation-
acetylation cycle enzymes, desaturase from fa desaturation pathways
is also considered to contribute to the described observations. It is
3 It is furthermore conceivable that the corresponding counterparts were not identified
by the metabolomics kit.
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hard to say whether my marker set reflects these changes in glyc-
erophospholipid metabolism. Possibly the different saturation degrees
of the fa side chains of the PCs, which ranges from one to five double
bonds, reflects the process described.
Changes in the cellular membrane that include a G protein-coupled
receptor seem to coincidence with aging, which at least affects G pro-
tein activity, cell morphology and cell homeostasis [54]. A common
feature of cellular senescence is an increased cell surface. Naru et al.
could observe in cell experiments that senescent cells revealed higher
uptake of PC species with long chain fa residues [54]. Alongside, the
number of special lipid rafts named calveolae increased with senes-
cence. Presumably, PC species were integrated into calveolae, which
contain calveolin-1 as a crucial component capable of cell cycle sup-
pression at G0/G1 phase4.
I found several species of PCs with decreased concentrations with
higher age and one PC species with elevated level. Thus, I consider
an altered consumption of phospholipids due to specific membrana-
ceous demands5 associated with senescence. The underlying mecha-
nisms might work as described by Engelmann and Wiedmann by the
scavenger receptor SR-BI as major mediator of selective phospholipids
(PC, SM and phosphatidylethanolamine (PE)) uptake from particles
like HDL and LDL [22]. Phospholipids can induce fast and dynamic
changes in the cell membrane composition after incorporation upon
demands of distinct cell functions. Three of the four replicated PCs
from the marker set showed a decrease starting around age of 51.
This leads to the assumption that these metabolites might be less as-
sociated with age but rather with menopause, which is also known
to influence the metabolism by hormonal changes. Unfortunately, in-
formation about menopausal status of the female subjects was not
available at the time of analysis. All other metabolites of the marker
set changed in an approximately linear manner implying the absence
of menopausal influences.
Further important components of cell membranes are sphingomye- sphingomyelins
(SMs)lins (SMs), especially of neuronal cells, as they influence membrane
fluidity by their degree of unsaturation and can act as part of sig-
nal transduction. Both Ichi et al. and Corre et al. reported the con-
junction between oxidative stress and SM metabolism, but in their
studies, oxidative stress accelerated the degradation of SMs to ce-
ramide (cer), what would be inconsistent with elevated SM levels in
the elder subjects in my thesis [37, 16]. However, another study iden-
tified cells that had adapted to chronic oxidative stress with altered
SM metabolism and major changes in membrane composition lead-
ing to stabilization [13]. The SM level elevations I observed might
4 At least senescent cells don’t divide anymore [11].
5 A double bond leads to a bend in molecular 3D-structure. A higher number of dou-
ble bonds thus makes the molecule bulkier than more saturated species and eventu-
ally results in higher membrane fluidity.
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indicate that healthily aging humans have effective mechanisms to
protect cells from oxidative stress accompanied by changes in SM me-
tabolism and incorporation of SMs into cell membranes, although this
deduction from cell culture should be considered with extra caution.
Noteworthy results were described in [77]. Sphingolipid species can
have completely opposite effects: some mediate anti-apoptotic effects
and some are involved in apoptosis signaling. Additionally, it was
observed that cer (SM derivative without the phosphocholine head
group) accumulates under many forms of stress6. The observations
about apoptotic/anti-apoptotic properties of sphingolipids and cer ac-
cumulation might also play a role in the SM elevations with higher age
observed in KORA7. The fact that SM synthesis is situated in the mito-
chondria [77] could provide a possible link to ACs as their changes are
distinctly connected to mitochondrial processes (discussed in the AC
paragraph below). In this context the proposed link between SM cycle
and Kennedy pathway brings my results in relation [9]. According to
the Bieberich paper, SMs and PCs build a cycle together with cer and PE
(‘cdp-choline/SM cycle’). The paper describes the cycle as a link be-
tween major metabolic pathways and cell-signaling function. Hence,
changes in PC and SM levels8 with older age might also be coherent.
Elevated serum levels of ACs may have different underlying reasons.acylcarnitines (ACs)
AC species are found as a consequence of incompletely oxidized fatty
acids due to an exceedance of β oxidation capacity and related path-
ways (i. e., higher rate of substrate use than energy demand with ac-
cumulated acyl-coenzyme A (CoA) that are converted to ACs that exit
cells and tissues), but also as a consequence of oxidative stress [57].
Acylcarnitines in turn show up in the blood and can thus function
as a mirror of fas metabolism. A recent rodent study by Noland et al.
gave rise to an age-associated interpretation of the increased AC lev-
els in blood as a health-beneficial emergence [57]. The studied Wistar
rats under high fat diet exhibited diminished carnitine and increased
AC levels in skeletal muscle cells upon perturbations in mitochondrial
fuel utilization, e. g., incomplete fatty acid oxidation. Supplemented
carnitine led to AC efflux, which in turn showed up in blood accompa-
nied by meliorated fuel metabolism and improved glucose tolerance.
Thus, the carnitine shuttle system is considered as prominent factor
for maintenance of mitochondrial performance and glucose home-
ostasis. In the context of my thesis, the observed higher levels of AC
with advanced age might indicate a relation of aging processes with
counteraction against oxidative damage in the mitochondria via ac-
tion of the carnitine-acylcarnitine shuttle.
6 cer is a pro-apoptotic second messenger with complex metabolism and further po-
tent relatives like cer-1-phosphate have impact on cell growth, differentiation, and
inflammation [12].
7 At least oncogene-induced cellular senescence results in an apoptosis resistance [11].
8 and presumably AC levels as well
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ACs’capability to reflect the intracellular fa metabolism needs to be
seized. Many studies support the key role of lipid metabolism in ag-
ing with lipid metabolites serving important functions therein [93].
Yan et al. support the evidence of decreased capacity in fa metabo-
lism in aged mammals by their study on rats. They found fas to be
the most important metabolites of aging (60% of all age-related me-
tabolites) with 8 unsaturated fas decreased (linoleic acid C18:2, oleic
acid C18:1, palmitoleic acid C16:1, arachidonic acid C20:4, linolenic
acid C18:3, docosahexaenoic acid C22:6, eicosapentaenoic acid C20:5,
and eicosatrienonic acid C20:3 – consistent to my results) and 4 sat-
urated fas increased (palmitic acid C16:0, stearic acid C18:0, myristic
acid C14:0, and nonacosanoic acid C29:0). The decrease of polyunsatu-
rated fas might be the result of an age-associated increase in oxidation
by free radicals.
The consequences of altered mitochondrial function in aging on the
energy metabolism was demonstrated in another publication. Coquin
et al. [15] refute the often made statement aging was a general func-
tional decline by showing that certain metabolic pathways were con-
cerned but others not. They challenged aged flies with hypoxia and
investigated their ability to recover. Pathways detected thereby were
downstream of TCA cycle and respiration (aerobic) but not in anaero-
bic glycolysis. This fits to the common perception that mitochondrial
function decline contributes substantially to overall function decline
both in Drosophila and mammals. Activity of certain enzymes in the
electron transport chain decreases with age (enzyme complexes I, II,
and IV) and other experiments revealed a strong down-regulation of
TCA cycle and respiratory enzymes with age with resulting higher uti-
lization of glucose and glycogen for ATP production9. Lawton and
colleagues also saw elevations in all but one measured metabolites
from energy metabolism [46].
Considering the metabolic fate of the amino acid histidine, there histidine
are two known contiguous possibilities. Its descent in blood with
higher age could indicate an advanced demand in tissues. The first
histidine consuming pathway is its metabolisation to the biogenic
amine histamine by a decarboxylation step. Histamine is known to
be involved in local immune responses and can act as neurotransmit-
ter. However, to my knowledge an association between histidine or
histamine and immunosenescence has not been reported so far. The
second metabolic pathway that consumes histidine produces carno-
sine. This dipeptide from β-alanine and L-histidine is found in vir-
tually all tissues, particularly in skeletal muscle cells and different
brain cells [20]. Due to its antioxidant characteristics, carnosine is
considered to be a naturally occuring anti-aging substance capable of
suppressing oxidative damage, glycation of proteins, and scavenging
9 As all other catabolic pathways are less efficiently producing ATP, glucose and glyco-
gen consumption is necessarily elevated
40 discussion
toxic molecules [34] that are all known to occur with aging process.
For instance, carnosine was shown to accomplish capture of lipoxida-
tion products and prevention of protein cross-linking [97]. Assuming
lower levels of histidine due to its consumption by carnosine biosyn-
thesis with advancing age, the observation of decreased histidine in
this thesis might reflect successful counteracting of the important ag-
ing implication of oxidative stress and its consequences and thus a
healthful aging process. However, Yan et al. report that antioxidants
carnosine and ergothioneine decrease with higher age and would
thus lead to a weakened antioxidant defense system [93]. Contrary to
the decrease in serum histidine concentrations observed here, Lawton
et al. found elevated levels of both histidine and histamine in urine.
These results together could also point to an altered renal excretion
of histidine [46].
An obvious link from ornithine to aging would be alterations inornithine
the urea cycle, but there seems to be no such reports in the literature.
However, Durante et al. published interesting results on arginase en-
zyme, which metabolizes arginine to ornithine, linked to nitric oxide
(NO) synthesis and vascular function [21]. The known age-dependent
up-regulation of arginase could produce the elevated ornithine lev-
els observed in my study (and in the Lawton study in urine [46]).
Also, the downstream enzymes that catabolize ornithine have been
associated with aging features. Polyamines are the products of or-
nithine decarboxylase (ODC) and were associated with endothelial
growth and subsequent vascular lesions. Vascular lesions and en-
dothelial dysfunction are considered as central features of many age-
associated vascular disorders. Ames dwarf mice show a prominent
delay in onset of aging and were studied by Bates et al. [6]. The au-
thors reported a post-transcriptional control of the ODC gene by mi-
croRNA (miRNA) that led to suppressed ODC activity and subsequent
lower polyamine synthesis in Ames dwarf compared to wild type
mice. An up-regulation of ODC activity and elevated ornithine levels
have been detected in normally aging rats [85]. Furthermore, a role
for miRNA in the aging process of humans has been unraveled recently
[58]. I surmise from these and my findings that a factor of healthy ag-
ing in humans could arise from the arginase-ODC metabolic pathway,
and that a knockdown of ODC gene product with subsequently de-
creased production of potentially harmful polyamines could possibly
explain the effects. Besides ODC, ornithine aminotransferase (OAT) cat-
alyzes the degradation of ornithine to the amino acid proline, which
is an essential component of collagen. Excessive collagen deposition
in endothelial extracellular matrix is also suggested to contribute to
vascular lesions. Up-regulated OAT gene has been associated with
aging in a mouse model of accelerated senescence (SAMP8 mice)[48].
Healthy aging thus could involve mechanisms for down-regulation of
OAT gene or enzyme activity. Significantly diminished proline levels
4.3 summary 41
in our elder subjects support the assumption of OAT down-regulation
(females 651 versus >51 years, p-value 9.7E-10).
These pathways originating from arginase with the consequence of
smooth muscle cell proliferation via increased polyamine levels could
be further intensified by the arginase mediated NO suppression, which
arises from competition between arginase and NO synthase for argi-
nine [21]. The lack of NO action would further exacerbate endothelial
damage.
4.3 summary
Aging is understood as a continuous and dynamic remodeling pro-
cess of the human organism accompanied by numerous losses and
gains on different levels including intermediate metabolism and cell
function [4]. My results of a large number of age-associated meta-
bolites and the replicated set of ten age discriminating metabolites,
that showed both increase and decrease with age, might reflect these
processes and help getting a more integral picture of aging organism.
Overall, I observed age-dependent differences in PC, SM, AC and AA
levels that might link to altered cell membrane composition, mito-
chondrial metabolism, and counteraction to oxidative stress, respec-
tively. Mitochondrial dysfunction probably plays the most important
role as I found hints in the literature to a large proportion of the
marker set (10 of 12 ACs/SMs/PCs in KORA or 9 of 10 in the repli-
cation/meta-analysis). Having in mind that anti-aging mechanisms
was proposed to be successful and effective in centenarians [4], I au-
daciously speculate that the observed alterations in the healthy older
study subjects indicate organismal reactions to deleterious modifica-
tions.
In the introduction I cited an article that raised two questions on
aging that metabolomics may answer [45]. After presenting and dis-
cussing my results, the answers from my point of view are that aging
has probably both qualitative (i. e., metabolites that show altered but
constant levels after a certain age, e. g., PC ae C42:4) and quantitative
effects (i. e., metabolites that show constantly changing levels with
age, e. g., SM C16:1). Whether the identified metabolites may serve
as biomarkers is probably not to be answered at this stage, because
identification of biomarkers needs several stages of proof. This study
might serve as a starting point to the whole proof procedure.
Figure 6 attempts on bringing the discussed age-associated effects
in my metabolite set into context to each other and should bring the
results into a systems biology view. It is thus based on my findings
and on the described results from the literature cited in the discus-
sion.
In summary, I identified a set of twelve potentially differentiating
markers for age in females by comparison of two age groups of the
42 discussion

























































































Figure 6: Depicting the results in a systemic view.
As metabolomics aims at an integral and systemic depiction of
the outcome, this figure attempts on summarizing my results and
bring it in a common context.
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KORA F4 study with respect to their metabolic profile. Ten out of the
twelve markers were successfully replicated in the TwinsUK study. Lit-
erature gives indications that these markers might be linked to aging
processes as the action of oxidative stress, alterations in cell morphol-
ogy, beta oxidation capacity, and vascular function. Thus, I think that
the set will help to better understand aging pathways and their sys-
temic concurrence and eventually help to enhance the understanding
of healthy aging and longevity.
4.4 strengths and limitations of the study
Although the present study was large in terms of sample size and phe-
notypically and metabolically well characterized, it should be noted
that this was a cross-sectional study, that does not allow irrevocable
conclusions of cause and consequence. Additionally, the presence of
cohort effects should be taken into consideration. The year of birth
might be linked to variations in risk of the outcome of interest, in par-
ticular health outcomes, due to shifts in population exposure to risk
factors over time [43]. However, I consider the cohort effect as a poten-
tial factor that possibly modified my results, but did not entirely gen-
erate the associations between metabolites and age. Issues with com-
parison to other metabolomics studies were noticeable, because dif-
ferent analytical settings result in different sets of metabolites. Also,
the biological specimen, study size, and proband inclusion criteria
deviate largely and hence hamper comparability and placement in
the current knowledge. Another critical point again arises from the
cross-sectional design. I cannot clearly say why a certain concentra-
tion changes with higher age as no conclusion about the flux of the
certain metabolites is possible. Whether the concentration is e. g., el-
evated because of higher demands with greater supply to tissues or
because of less uptake and consumption of the tissue and thus an
accumulation in the blood is not clear for the majority of metabolites.
The Biocrates kit bears the challenge that the functions of many of
the identified molecules are not well known so far. Therefore, their lo-
calization in the cell might be unknown and particularly the reasons
why these occur in blood are unclear. For instance, SMs are synthe-
sized in the cell and then incorporated in membranes, but no known
scenario of secretion into the blood is described yet. Altogether, this
exacerbates interpretation of the results. However, knowledge bases
like HMDB [36] are growing quickly and provide ameliorating possi-
bilities.
To cope with the complexity of aging process on the level of small
molecules, metabolomics technology was used capable of the detec-
tion of a large number of molecules simultaneously. I consider small
molecules as very suitable age markers as they are easily obtained
from blood samples and analyzed in a relatively inexpensive and
44 discussion
quick manner. The kit has been successfully used in several previous
studies (e. g., in [38, 94]). However, taking together complex results to
an integrative picture requires good bioinformatics tools and patient
literature search.
5
P E R S P E C T I V E S
Further research on the metabolic surrounding of the metabolite set
could eventually lead to the possibility to early determine a person’s
potential for healthy aging at the beginning of the remodeling process.
However, it seems not strongly confirmed yet that effects of cellular
senescence also occur in vivo [54]. Nevertheless, I suspect the set of
twelve markers to have the potential to reflect different age-associated
metabolic alterations of females at once. To ensure the absence of co-
hort effects and other disadvantages of the cross-sectional study de-
sign, I plan to analyze metabolomics results from a subset of KORA S4,
the previous examination to KORA F4. Thereby, I will be able to an-
alyze the concentration course of these metabolites from two time
points with seven years in between and get results of real aging. Ad-
ditionally, menopause status of the KORA F4 women is available mean-
while and will eventually clarify whether the inflection point around
age 51 is due to hormonal changes. An already ongoing attempt re-
gards epigenetic changes, i. e., cytosine methylation differences, with
age in KORA F4.
It might be very promising (but also challenging) to combine me-
tabolomics measurements from different platforms with other -omics
data, analyze them with the continuously newly launched bioinfor-
matics tools and interpret the results with constantly growing knowl-
edge on human metabolism.
Interesting insights are expected from a closer look onto the males
and the reason why they differ distinctly from women in their metabol-
ic changes. However, as Berdasco and colleagues pointed out, the
greatest barriers in conducting studies on age are the long time peri-
ods, that would be necessary to really examine the aging process in















































































































































































Figure 7: Heat map of KORA F4 males.The heat map shows changes of fold
standard deviation from the overall mean concentration for each
year in a color-coded way, and clustering of these changes. Green
squares represent a decrease, and red squares an increase. Gray
boxes represent groups of metabolites with similar changes with
number of metabolites in parentheses. Metabolite names in red in-
dicate the set of 12 metabolites (see 3.2.2). amino acid (AA); acylcar-
nitine (AC); diacyl phosphatidylcholine (PC aa); acyl-alkyl phospha-
tidylcholine (PC ae); and lyso phosphatidylcholine acyl (lyso PC a).
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Figure 8: Smoother plots for TwinsUK females (replication). Concentration
courses of the 12 metabolites in TwinsUK females were largely com-
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Figure 9: Smoother plots for KORA F4 males – concentration courses of the
15 metabolites for KORA F4 males
A.1 figure appendix 51












































































































Figure 10: Cluster plots for age for KORA F4 females (A) and males (B)
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 10: Results from BMI-adjusted linear regression in KORA F4 females;
? below significance level
metabolite estimate SE p-value
C12:1 0.009 0.001 1.58E-40 ?
C10:1 0.010 0.001 2.70E-37 ?
PC ae C36:1 0.007 0.001 3.76E-37 ?
C18 0.008 0.001 1.21E-36 ?
C16:2 0.010 0.001 2.06E-35 ?
PC aa C28:1 0.007 0.001 3.83E-33 ?
C18:1 0.007 0.001 4.24E-33 ?
C16:1 0.007 0.001 1.78E-32 ?
C16 0.006 0.001 1.42E-29 ?
C14:1-OH 0.007 0.001 2.78E-29 ?
SM C16:1 0.005 4.11E-04 1.28E-28 ?
C5 0.008 0.001 2.89E-28 ?
C10:2 0.006 0.001 2.13E-27 ?
PC ae C40:2 0.006 0.001 5.36E-26 ?
C2 0.008 0.001 1.69E-24 ?
C8 0.008 0.001 1.21E-23 ?
C14:1 0.006 0.001 3.39E-23 ?
PC ae C34:0 0.006 0.001 6.66E-23 ?
C14:2 0.009 0.001 3.33E-22 ?
SM (OH) C16:1 0.006 0.001 6.47E-22 ?
C14 0.005 0.001 1.44E-21 ?
SM C18:1 0.005 0.001 1.14E-20 ?
SM (OH) C22:2 0.005 0.001 5.17E-20 ?
C12 0.007 0.001 1.03E-19 ?
C18:2 0.006 0.001 1.83E-19 ?
PC ae C32:2 0.005 0.001 3.28E-19 ?
PC aa C38:5 0.005 0.001 6.02E-19 ?
PC aa C40:6 0.007 0.001 7.00E-19 ?
C0 0.005 0.001 1.03E-18 ?
PC aa C32:0 0.004 4.70E-04 1.59E-18 ?
SM (OH) C14:1 0.005 0.001 2.64E-18 ?
PC aa C40:2 0.005 0.001 8.03E-18 ?
PC aa C40:5 0.005 0.001 1.26E-17 ?
SM C18:0 0.004 4.79E-04 1.62E-17 ?
C10 0.008 0.001 2.51E-17 ?
SM C16:0 0.003 3.72E-04 4.14E-17 ?
C3 0.006 0.001 4.53E-17 ?
PC aa C40:3 0.004 0.001 3.61E-14 ?
SM C26:1 0.006 0.001 7.96E-14 ?
C4 0.007 0.001 8.01E-14 ?
PC aa C36:1 0.004 0.001 1.01E-13 ?
PC aa C38:4 0.004 0.001 1.12E-13 ?
PC ae C38:1 0.006 0.001 1.53E-13 ?
SM (OH) C24:1 0.004 0.001 4.45E-13 ?
PC aa C30:0 0.005 0.001 8.15E-13 ?
SM (OH) C22:1 0.004 0.001 1.29E-12 ?
PC ae C38:2 0.004 0.001 1.82E-12 ?
A.2 table appendix 63
Table 10: Linear regression females (cont.)
metabolite estimate SE p-value
Orn 0.004 0.001 2.72E-12 ?
PC aa C36:5 0.007 0.001 2.78E-12 ?
PC aa C38:3 0.004 0.001 5.61E-12 ?
His -0.002 3.61E-04 1.10E-11 ?
PC ae C40:0 0.002 3.48E-04 1.94E-11 ?
PC aa C32:3 0.004 0.001 2.28E-11 ?
Thr -0.004 0.001 3.66E-11 ?
PC ae C40:1 0.004 0.001 4.01E-11 ?
PC ae C38:3 0.003 0.001 1.64E-10 ?
PC ae C36:2 0.003 0.001 6.42E-10 ?
Val -0.003 4.32E-04 3.19E-09 ?
SM C24:0 0.003 4.79E-04 3.49E-09 ?
PC ae C36:5 0.004 0.001 4.17E-09 ?
SM C24:1 0.003 4.44E-04 8.80E-09 ?
PC aa C38:6 0.004 0.001 1.01E-08 ?
PC ae C42:0 0.003 4.60E-04 1.28E-08 ?
Tyr 0.003 0.001 1.40E-08 ?
PC ae C40:6 0.003 0.001 1.42E-08 ?
PC ae C38:6 0.003 0.001 3.76E-08 ?
PC ae C42:1 0.003 0.001 4.83E-08 ?
PC ae C34:1 0.003 4.89E-04 5.18E-08 ?
Trp -0.002 2.98E-04 7.36E-08 ?
PC aa C36:2 0.002 4.35E-04 8.20E-08 ?
PC aa C32:1 0.005 0.001 1.95E-07 ?
PC aa C42:4 0.002 4.92E-04 5.24E-07 ?
C8:1 0.005 0.001 6.60E-07 ?
PC aa C40:4 0.003 0.001 1.89E-06 ?
PC ae C40:3 0.002 4.77E-04 2.38E-06 ?
lysoPC a C18:0 0.003 0.001 3.30E-06 ?
Ser -0.002 4.91E-04 3.66E-06 ?
xLeu -0.002 4.23E-04 4.08E-06 ?
PC ae C42:2 0.002 0.001 5.76E-06 ?
PC ae C38:5 0.002 0.001 5.93E-06 ?
PC aa C32:2 0.005 0.001 7.67E-06 ?
PC aa C36:6 0.004 0.001 7.90E-06 ?
PC aa C38:0 0.003 0.001 1.14E-05 ?
PC aa C34:4 0.004 0.001 1.36E-05 ?
PC aa C40:1 0.002 4.51E-04 1.46E-05 ?
PC ae C30:0 0.003 0.001 2.36E-05 ?
PC ae C44:4 -0.003 0.001 2.45E-05 ?
PC ae C42:4 -0.002 0.001 5.44E-05 ?
PC aa C34:3 0.003 0.001 1.14E-04 ?
PC ae C44:5 -0.002 0.001 1.21E-04 ?
PC ae C40:5 0.002 4.56E-04 1.53E-04 ?
PC aa C42:2 0.002 0.001 1.56E-04 ?
PC aa C36:4 0.002 0.001 1.57E-04 ?
C6(C4:1-DC) 0.003 0.001 2.31E-04 ?
PC ae C38:4 0.002 4.93E-04 2.78E-04 ?
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Table 10: Linear regression females (cont.)
metabolite estimate SE p-value
lysoPC a C17:0 0.003 0.001 3.78E-04 ?
PC ae C32:1 0.002 4.92E-04 4.17E-04
PC ae C42:5 -0.002 4.97E-04 7.60E-04
PC aa C42:5 0.002 0.001 8.95E-04
H1 0.001 3.17E-04 0.001
lysoPC a C18:2 -0.002 0.001 0.001
PC aa C36:3 0.002 0.001 0.002
PC aa C42:6 0.001 4.87E-04 0.002
PC ae C38:0 0.002 0.001 0.004
Arg 0.001 4.37E-04 0.005
PC aa C34:1 0.001 0.001 0.008
C9 0.003 0.001 0.009
PC ae C44:3 0.002 0.001 0.010
PC ae C30:2 0.001 0.001 0.019
PC aa C36:0 0.002 0.001 0.025
PC ae C44:6 -0.001 0.001 0.037
Met -0.001 4.46E-04 0.040
PC ae C34:2 0.001 0.001 0.154
Gly 0.001 0.001 0.169
lysoPC a C16:1 0.001 0.001 0.232
PC ae C36:4 0.001 0.001 0.251
SM C20:2 -0.001 0.001 0.290
Phe -4.06E-04 3.93E-04 0.303
lysoPC a C16:0 3.99E-04 0.001 0.453
Pro -4.65E-04 0.001 0.518
PC aa C34:2 2.42E-04 3.89E-04 0.535
PC ae C40:4 2.94E-04 4.81E-04 0.541
Gln -2.35E-04 3.89E-04 0.547
PC ae C34:3 -3.52E-04 0.001 0.585
PC ae C42:3 2.54E-04 0.001 0.629
lysoPC a C20:4 2.50E-04 0.001 0.731
lysoPC a C18:1 1.98E-04 0.001 0.772
PC aa C42:1 -1.56E-04 0.001 0.814
lysoPC a C20:3 1.34E-04 0.001 0.848
PC ae C36:3 7.65E-05 0.001 0.888
PC aa C42:0 6.01E-05 0.001 0.930
Table 11: Results from BMI-adjusted linear regression in KORA F4 males;
? below significance level
metabolite estimate SE p-value
Trp -0.003 2.78E-04 3.67E-33 ?
Val -0.005 4.00E-04 6.61E-31 ?
C16:1 0.007 0.001 1.60E-26 ?
His -0.004 3.36E-04 2.67E-26 ?
C12 0.008 0.001 3.50E-26 ?
C16:2 0.009 0.001 3.65E-26 ?
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Table 11: Linear regression males (cont.)
metabolite estimate SE p-value
xLeu -0.004 4.03E-04 7.83E-25 ?
lysoPC a C20:3 -0.006 0.001 4.54E-22 ?
C18:1 0.006 0.001 3.09E-20 ?
C10:1 0.007 0.001 2.38E-19 ?
C2 0.007 0.001 3.54E-19 ?
lysoPC a C18:2 -0.006 0.001 3.90E-19 ?
Thr -0.004 4.92E-04 1.29E-15 ?
C14:1-OH 0.005 0.001 4.99E-15 ?
C16 0.004 0.001 4.46E-14 ?
lysoPC a C20:4 -0.005 0.001 8.63E-14 ?
Met -0.003 4.07E-04 3.09E-13 ?
Gln -0.003 3.74E-04 1.40E-12 ?
PC ae C42:0 0.003 4.42E-04 2.54E-12 ?
C18:2 0.005 0.001 4.42E-12 ?
C14:2 0.007 0.001 1.35E-11 ?
PC ae C36:4 -0.004 0.001 2.63E-11 ?
PC ae C40:2 0.004 0.001 5.34E-11 ?
C6(C4:1-DC) 0.005 0.001 8.42E-11 ?
C8 0.006 0.001 1.09E-10 ?
PC ae C32:2 0.003 4.90E-04 1.20E-10 ?
C14 0.004 0.001 2.72E-10 ?
C18 0.004 0.001 2.56E-09 ?
PC aa C40:2 0.004 0.001 2.59E-09 ?
C12:1 0.005 0.001 4.28E-09 ?
Pro -0.004 0.001 4.68E-09 ?
PC ae C36:1 0.003 0.001 9.88E-09 ?
SM C24:0 -0.003 4.64E-04 2.93E-08 ?
PC ae C34:0 0.003 0.001 6.53E-08 ?
lysoPC a C18:1 -0.003 0.001 1.16E-07 ?
PC aa C32:0 0.003 4.74E-04 1.37E-07 ?
C10 0.005 0.001 2.55E-07 ?
C10:2 0.003 0.001 2.90E-07 ?
Gly -0.002 4.73E-04 5.20E-07 ?
PC aa C34:4 -0.004 0.001 1.05E-06 ?
Ser -0.002 4.48E-04 1.19E-06 ?
PC ae C40:3 0.002 4.69E-04 3.42E-06 ?
C14:1 0.003 0.001 7.68E-06 ?
PC aa C40:6 0.003 0.001 1.34E-05 ?
SM (OH) C16:1 0.002 0.001 1.34E-05 ?
lysoPC a C18:0 -0.002 0.001 1.48E-05 ?
PC ae C38:1 0.003 0.001 2.16E-05 ?
PC aa C38:3 -0.002 0.001 2.98E-05 ?
PC aa C40:4 -0.003 0.001 3.40E-05 ?
lysoPC a C16:0 -0.002 4.58E-04 3.58E-05 ?
PC aa C42:4 0.002 4.78E-04 4.54E-05 ?
PC ae C40:0 0.001 3.39E-04 4.63E-05 ?
PC ae C32:1 0.002 4.71E-04 4.91E-05 ?
PC ae C38:5 -0.002 0.001 5.77E-05 ?
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Table 11: Linear regression males (cont.)
metabolite estimate SE p-value
SM (OH) C14:1 0.002 0.001 6.96E-05 ?
PC aa C36:4 -0.002 0.001 6.99E-05 ?
PC aa C38:6 0.003 0.001 9.41E-05 ?
PC ae C34:1 0.002 4.59E-04 1.41E-04 ?
PC aa C28:1 0.002 0.001 1.87E-04 ?
PC aa C40:3 0.002 0.001 2.47E-04 ?
PC aa C36:2 -0.002 4.46E-04 3.48E-04 ?
PC ae C36:5 -0.002 0.001 3.82E-04
SM C26:1 0.002 0.001 4.73E-04
C5 -0.002 0.001 0.001
PC aa C36:3 -0.002 4.87E-04 0.001
PC aa C38:4 -0.002 0.001 0.001
PC aa C40:1 0.002 4.55E-04 0.001
PC aa C42:0 0.002 0.001 0.001
PC ae C36:3 -0.002 0.001 0.001
Phe -0.001 3.74E-04 0.001
SM C16:0 0.001 3.81E-04 0.001
PC aa C34:2 -0.001 4.06E-04 0.002
PC ae C30:0 0.002 0.001 0.002
PC ae C30:2 -0.002 0.001 0.002
PC ae C38:2 0.002 0.001 0.002
PC ae C44:3 0.002 0.001 0.002
SM (OH) C22:1 -0.002 0.001 0.002
PC aa C36:0 -0.002 0.001 0.003
PC aa C36:1 -0.002 0.001 0.003
PC aa C42:2 0.002 0.001 0.003
PC ae C38:4 -0.001 4.75E-04 0.003
PC aa C30:0 0.002 0.001 0.004
PC ae C36:2 0.002 0.001 0.006
PC ae C40:6 0.002 0.001 0.006
SM C16:1 0.001 4.07E-04 0.008
PC aa C42:5 0.002 0.001 0.010
SM C20:2 -0.002 0.001 0.010
PC ae C38:0 -0.002 0.001 0.013
lysoPC a C16:1 -0.002 0.001 0.015
PC ae C34:3 -0.001 0.001 0.022
PC aa C40:5 -0.001 0.001 0.025
PC ae C40:1 -0.001 0.001 0.026
PC aa C34:1 -0.001 0.001 0.029
PC ae C38:6 -0.001 0.001 0.029
C8:1 0.002 0.001 0.041
PC ae C42:3 0.001 0.001 0.048
PC ae C44:6 0.001 0.001 0.056
SM (OH) C24:1 -0.001 0.001 0.057
C4 0.002 0.001 0.072
Tyr -0.001 4.41E-04 0.091
Arg -0.001 4.53E-04 0.126
PC aa C36:6 -0.001 0.001 0.128
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Table 11: Linear regression males (cont.)
metabolite estimate SE p-value
PC aa C42:6 -0.001 0.001 0.132
PC aa C38:5 -0.001 0.001 0.147
SM (OH) C22:2 0.001 0.001 0.173
C3 -0.001 0.001 0.207
PC aa C42:1 0.001 0.001 0.224
Orn -0.001 0.001 0.244
H1 3.14E-04 2.82E-04 0.265
PC ae C34:2 -0.001 0.001 0.267
PC aa C32:1 0.001 0.001 0.291
PC aa C34:3 -0.001 0.001 0.310
PC aa C32:3 -0.001 0.001 0.316
C0 -4.58E-04 4.62E-04 0.321
PC ae C38:3 4.15E-04 0.001 0.421
C9 0.001 0.001 0.422
SM C24:1 -3.59E-04 4.51E-04 0.426
lysoPC a C17:0 -4.96E-04 0.001 0.453
SM C18:0 3.44E-04 4.65E-04 0.459
SM C18:1 3.61E-04 4.93E-04 0.464
PC aa C36:5 0.001 0.001 0.516
PC aa C38:0 3.98E-04 0.001 0.525
PC ae C40:4 -2.78E-04 4.60E-04 0.546
PC ae C42:4 2.96E-04 0.001 0.594
PC ae C42:1 -2.80E-04 0.001 0.641
PC aa C32:2 -4.24E-04 0.001 0.679
PC ae C40:5 -1.49E-04 4.41E-04 0.736
PC ae C44:5 -1.91E-04 0.001 0.760
PC ae C42:5 -1.07E-04 4.89E-04 0.827
PC ae C42:2 -2.56E-05 0.001 0.961
PC ae C44:4 2.29E-05 0.001 0.970

B I B L I O G R A P H Y
[1] Jerzy Adamski and Karsten Suhre. Metabolomics platforms for genome wide association
studies-linking the genome to the metabolome. Curr Opin Biotechnol, 24(1):39–47, Feb 2013.
doi: 10.1016/j.copbio.2012.10.003. URL http://dx.doi.org/10.1016/j.copbio.2012.10.
003. (Cited on pages 8 and 9.)
[2] T. Andrew, D. J. Hart, H. Snieder, M. de Lange, T. D. Spector, and A. J. MacGregor. Are
twins and singletons comparable? a study of disease-related and lifestyle characteristics
in adult women. Twin Res, 4(6):464–477, Dec 2001. (Cited on page 22.)
[3] Baltic Analytics, Jan 2013. URL http://www.baltic-analytics.de/index.php?id=8&L=1.
(Cited on page 11.)
[4] Michelangela Barbieri, Virginia Boccardi, Michela Papa, and Giuseppe Paolisso. Metabolic
journey to healthy longevity. Horm Res, 71 Suppl 1:24–27, Jan 2009. doi: 10.1159/000178032.
URL http://dx.doi.org/10.1159/000178032. (Cited on pages 6, 36, and 41.)
[5] Nir Barzilai, Gil Atzmon, Clyde Schechter, Ernst J. Schaefer, Adrienne L. Cupples, Richard
Lipton, Suzanne Cheng, and Alan R. Shuldiner. Unique lipoprotein phenotype and geno-
type associated with exceptional longevity. JAMA, 290(15):2030–2040, Oct 2003. doi:
10.1001/jama.290.15.2030. URL http://dx.doi.org/10.1001/jama.290.15.2030. (Cited
on page 7.)
[6] David J. Bates, Na Li, Ruqiang Liang, Harshini Sarojini, Jin An, Michal M. Masternak,
Andrzej Bartke, and Eugenia Wang. Microrna regulation in ames dwarf mouse liver may
contribute to delayed aging. Aging Cell, 9(1):1–18, Feb 2010. doi: 10.1111/j.1474-9726.
2009.00529.x. URL http://dx.doi.org/10.1111/j.1474-9726.2009.00529.x. (Cited on
page 40.)
[7] María Berdasco and Manel Esteller. Hot topics in epigenetic mechanisms of aging: 2011.
Aging Cell, 11(2):181–186, Apr 2012. doi: 10.1111/j.1474-9726.2012.00806.x. URL http:
//dx.doi.org/10.1111/j.1474-9726.2012.00806.x. (Cited on pages 3 and 45.)
[8] Hanne Christine Bertram, Jens Ø. Duus, Bent O. Petersen, Camilla Hoppe, Anni Larnkjaer,
Lene Schack-Nielsen, Christian Mølgaard, and Kim F. Michaelsen. Nuclear magnetic
resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-
old scandinavians and correlation to retrospective infant plasma parameters. Metabolism,
58(7):1039–1045, Jul 2009. doi: 10.1016/j.metabol.2009.03.011. URL http://dx.doi.org/
10.1016/j.metabol.2009.03.011. (Cited on page 16.)
[9] Erhard Bieberich. Ceramide signaling in cancer and stem cells. Future Lipidol, 3(3):273–300,
Jun 2008. doi: 10.2217/17460875.3.3.273. URL http://dx.doi.org/10.2217/17460875.3.
3.273. (Cited on page 38.)
[10] Robert N. Butler, Richard A. Miller, Daniel Perry, Bruce A. Carnes, T Franklin Williams,
Christine Cassel, Jacob Brody, Marie A. Bernard, Linda Partridge, Thomas Kirkwood,
George M. Martin, and S Jay Olshansky. New model of health promotion and disease
prevention for the 21st century. BMJ, 337:a399, 2008. (Cited on page 2.)
[11] Judith Campisi and Fabrizio d’Adda di Fagagna. Cellular senescence: when bad things
happen to good cells. Nat Rev Mol Cell Biol, 8(9):729–740, Sep 2007. doi: 10.1038/nrm2233.
URL http://dx.doi.org/10.1038/nrm2233. (Cited on pages 37 and 38.)
[12] Hui Chen, Julie-Thu A. Tran, Richard S. Brush, Anisse Saadi, Abul K. Rahman, Man Yu,
Douglas Yasumura, Michael T. Matthes, Kelly Ahern, Haidong Yang, Matthew M. LaVail,
and Md Nawajes A. Mandal. Ceramide signaling in retinal degeneration. Adv Exp Med
Biol, 723:553–558, 2012. doi: 10.1007/978-1-4614-0631-0_70. URL http://dx.doi.org/10.
1007/978-1-4614-0631-0_70. (Cited on page 38.)
[13] Angela B. Clement, Martin Gamerdinger, Irfan Y. Tamboli, Dieter Lütjohann, Jochen Wal-
ter, Isabell Greeve, Gerald Gimpl, and Christian Behl. Adaptation of neuronal cells to
chronic oxidative stress is associated with altered cholesterol and sphingolipid home-
ostasis and lysosomal function. J Neurochem, 111(3):669–682, Nov 2009. doi: 10.1111/
j.1471-4159.2009.06360.x. URL http://dx.doi.org/10.1111/j.1471-4159.2009.06360.x.
(Cited on page 37.)
69
70 bibliography
[14] William S Cleveland and Susan T Devlin. Locally weighted regression: An approach to
regression analysis by local fitting. J. Am. Stat. Assoc., 83(403):596–610, Sep. 1988. URL
http://www.jstor.org/stable/2289282. (Cited on page 22.)
[15] Laurence Coquin, Jacob D. Feala, Andrew D. McCulloch, and Giovanni Paternostro.
Metabolomic and flux-balance analysis of age-related decline of hypoxia tolerance in
drosophila muscle tissue. Mol Syst Biol, 4:233, 2008. doi: 10.1038/msb.2008.71. URL
http://dx.doi.org/10.1038/msb.2008.71. (Cited on pages 15 and 39.)
[16] Isabelle Corre, Colin Niaudet, and Francois Paris. Plasma membrane signaling induced
by ionizing radiation. Mutat Res, 704(1-3):61–67, 2010. doi: 10.1016/j.mrrev.2010.01.014.
URL http://dx.doi.org/10.1016/j.mrrev.2010.01.014. (Cited on page 37.)
[17] Pio D’Adamo, Sheila Ulivi, Amerigo Beneduci, Gabriele Pontoni, Giovambattista Capasso,
Carmela Lanzara, Gilberto Andrighetto, Uros Hladnik, Virginia Nunes, Manuel Palacin,
and Paolo Gasparini. Metabonomics and population studies: age-related amino acids ex-
cretion and inferring networks through the study of urine samples in two italian isolated
populations. Amino Acids, 38(1):65–73, Jan 2010. doi: 10.1007/s00726-008-0205-8. URL
http://dx.doi.org/10.1007/s00726-008-0205-8. (Cited on page 16.)
[18] Jennifer M. De Guzman, Ginger Ku, Ryan Fahey, Yun-Hee Youm, Ignatius Kass, Donald K.
Ingram, Vishwa Deep Dixit, and Indu Kheterpal. Chronic caloric restriction partially
protects against age-related alteration in serum metabolome. Age (Dordr), Jun 2012. doi: 10.
1007/s11357-012-9430-x. URL http://dx.doi.org/10.1007/s11357-012-9430-x. (Cited
on pages 15 and 36.)
[19] Joao Pedro de Magalhaes, Arie Budovsky, Gilad Lehmann, Joana Costa, Yang Li, Vadim
Fraifeld, and George M. Church. The human ageing genomic resources: online databases
and tools for biogerontologists. Aging Cell, 8(1):65–72, Feb 2009. doi: 10.1111/j.1474-9726.
2008.00442.x. URL http://dx.doi.org/10.1111/j.1474-9726.2008.00442.x. (Cited on
page 32.)
[20] Wim Derave, Inge Everaert, Sam Beeckman, and Audrey Baguet. Muscle carnosine me-
tabolism and beta-alanine supplementation in relation to exercise and training. Sports
Med, 40(3):247–263, Mar 2010. doi: 10.2165/11530310-000000000-00000. URL http:
//dx.doi.org/10.2165/11530310-000000000-00000. (Cited on page 39.)
[21] William Durante, Fruzsina K. Johnson, and Robert A. Johnson. Arginase: a critical reg-
ulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol, 34(9):
906–911, Sep 2007. doi: 10.1111/j.1440-1681.2007.04638.x. URL http://dx.doi.org/10.
1111/j.1440-1681.2007.04638.x. (Cited on pages 40 and 41.)
[22] Bernd Engelmann and Markus K H. Wiedmann. Cellular phospholipid uptake: flexible
paths to coregulate the functions of intracellular lipids. Biochim Biophys Acta, 1801(6):
609–616, Jun 2010. doi: 10.1016/j.bbalip.2010.02.013. URL http://dx.doi.org/10.1016/j.
bbalip.2010.02.013. (Cited on page 37.)
[23] Anne M. Evans, Corey D. DeHaven, Tom Barrett, Matt Mitchell, and Eric Milgram. In-
tegrated, nontargeted ultrahigh performance liquid chromatography/electrospray ioniza-
tion tandem mass spectrometry platform for the identification and relative quantification
of the small-molecule complement of biological systems. Anal Chem, 81(16):6656–6667,
Aug 2009. doi: 10.1021/ac901536h. URL http://dx.doi.org/10.1021/ac901536h. (Cited
on pages 9 and 12.)
[24] Bruno César Feltes, Joice de Faria Poloni, and Diego Bonatto. The developmental aging
and origins of health and disease hypotheses explained by different protein networks.
Biogerontology, 12(4):293–308, Aug 2011. doi: 10.1007/s10522-011-9325-8. URL http://dx.
doi.org/10.1007/s10522-011-9325-8. (Cited on pages 5 and 35.)
[25] Luigi Ferrucci, Francesco Giallauria, and Jack M. Guralnik. Epidemiology of aging. Radiol
Clin North Am, 46(4):643–52, v, Jul 2008. doi: 10.1016/j.rcl.2008.07.005. URL http://dx.doi.
org/10.1016/j.rcl.2008.07.005. (Cited on pages 2 and 3.)
[26] P. Filzmoser, R. Maronna, , and M. Werner. Outlier identification in high dimensions. Com-
putational Statistics & Data Analysis, 52(3):1694–1711, 2008. URL ISI:000253669700032.
Times Cited: 12 Article English Filzmoser, P Vienna Univ Technol, Dept Stat & Proba-
bil Theory, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria Cited References Count: 32
269SE PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS AMSTERDAM. (Cited on
page 21.)
bibliography 71
[27] Luigi Fontana, Linda Partridge, and Valter D. Longo. Extending healthy life span–from
yeast to humans. Science, 328(5976):321–326, Apr 2010. doi: 10.1126/science.1172539. URL
http://dx.doi.org/10.1126/science.1172539. (Cited on pages 8 and 35.)
[28] Claudio Franceschi, Miriam Capri, Daniela Monti, Sergio Giunta, Fabiola Olivieri, Fed-
erica Sevini, Maria Panagiota Panourgia, Laura Invidia, Laura Celani, Maria Scurti,
Elisa Cevenini, Gastone C. Castellani, and Stefano Salvioli. Inflammaging and anti-
inflammaging: a systemic perspective on aging and longevity emerged from studies in
humans. Mech Ageing Dev, 128(1):92–105, Jan 2007. doi: 10.1016/j.mad.2006.11.016. URL
http://dx.doi.org/10.1016/j.mad.2006.11.016. (Cited on page 3.)
[29] Christian Gieger, Ludwig Geistlinger, Elisabeth Altmaier, Martin Hrabé de Angelis, Flo-
rian Kronenberg, Thomas Meitinger, Hans-Werner Mewes, H-Erich Wichmann, Klaus M.
Weinberger, Jerzy Adamski, Thomas Illig, and Karsten Suhre. Genetics meets metabo-
lomics: a genome-wide association study of metabolite profiles in human serum. PLoS
Genet, 4(11):e1000282, Nov 2008. doi: 10.1371/journal.pgen.1000282. URL http://dx.doi.
org/10.1371/journal.pgen.1000282. (Cited on page 32.)
[30] Haiwei Gu, Zhengzheng Pan, Bowei Xi, Bryan E. Hainline, Narasimhamurthy Shanaiah,
Vincent Asiago, G A Nagana Gowda, and Daniel Raftery. 1h nmr metabolomics study of
age profiling in children. NMR Biomed, 22(8):826–833, Oct 2009. doi: 10.1002/nbm.1395.
URL http://dx.doi.org/10.1002/nbm.1395. (Cited on page 16.)
[31] David E. Harrison, Randy Strong, Zelton Dave Sharp, James F. Nelson, Clinton M. Astle,
Kevin Flurkey, Nancy L. Nadon, J Erby Wilkinson, Krystyna Frenkel, Christy S. Carter,
Marco Pahor, Martin A. Javors, Elizabeth Fernandez, and Richard A. Miller. Rapamycin
fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460(7253):392–
395, Jul 2009. doi: 10.1038/nature08221. URL http://dx.doi.org/10.1038/nature08221.
(Cited on page 8.)
[32] Leonard Hayflick. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci,
1100:1–13, Apr 2007. doi: 10.1196/annals.1395.001. URL http://dx.doi.org/10.1196/
annals.1395.001. (Cited on pages 1, 4, and 33.)
[33] C. J. Henry. Mechanisms of changes in basal metabolism during ageing. Eur J Clin Nutr,
54 Suppl 3:S77–S91, Jun 2000. (Cited on pages 1 and 5.)
[34] Alan R. Hipkiss. Aging, proteotoxicity, mitochondria, glycation, nad and carnosine: Pos-
sible inter-relationships and resolution of the oxygen paradox. Front Aging Neurosci, 2:
10, 2010. doi: 10.3389/fnagi.2010.00010. URL http://dx.doi.org/10.3389/fnagi.2010.
00010. (Cited on page 40.)
[35] A. J. Hulbert. On the importance of fatty acid composition of membranes for aging. J
Theor Biol, 234(2):277–288, May 2005. doi: 10.1016/j.jtbi.2004.11.024. URL http://dx.doi.
org/10.1016/j.jtbi.2004.11.024. (Cited on page 5.)
[36] Human metabolome project, 2013. URL http://www.hmdb.ca/statistics. (Cited on
pages 10 and 43.)
[37] Ikuyo Ichi, Chiaki Kamikawa, Tomoka Nakagawa, Keiko Kobayashi, Ryoko Kataoka, Eri
Nagata, Yuko Kitamura, Chihiro Nakazaki, Tatsuya Matsura, and Shosuke Kojo. Neu-
tral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon
tetrachloride intoxication. Toxicology, 261(1-2):33–40, Jun 2009. doi: 10.1016/j.tox.2009.04.
040. URL http://dx.doi.org/10.1016/j.tox.2009.04.040. (Cited on page 37.)
[38] Thomas Illig, Christian Gieger, Guangju Zhai, Werner Römisch-Margl, Rui Wang-Sattler,
Cornelia Prehn, Elisabeth Altmaier, Gabi Kastenmüller, Bernet S. Kato, Hans-Werner
Mewes, Thomas Meitinger, Martin Hrabé de Angelis, Florian Kronenberg, Nicole Soranzo,
H-Erich Wichmann, Tim D. Spector, Jerzy Adamski, and Karsten Suhre. A genome-wide
perspective of genetic variation in human metabolism. Nat Genet, 42(2):137–141, Feb 2010.
doi: 10.1038/ng.507. URL http://dx.doi.org/10.1038/ng.507. (Cited on pages 20, 32,
and 44.)
[39] Lars J. Jensen, Michael Kuhn, Manuel Stark, Samuel Chaffron, Chris Creevey, Jean Muller,
Tobias Doerks, Philippe Julien, Alexander Roth, Milan Simonovic, Peer Bork, and Chris-
tian von Mering. String 8–a global view on proteins and their functional interactions
in 630 organisms. Nucleic Acids Res, 37(Database issue):D412–D416, Jan 2009. doi:
10.1093/nar/gkn760. URL http://dx.doi.org/10.1093/nar/gkn760. (Cited on page 32.)
72 bibliography
[40] Hong Jiang, Eric Schiffer, Zhangfa Song, Jianwei Wang, Petra Zürbig, Kathrin Thedieck,
Suzette Moes, Heike Bantel, Nadja Saal, Justyna Jantos, Meiken Brecht, Paul Jenö,
Michael N. Hall, Klaus Hager, Michael P. Manns, Hartmut Hecker, Arnold Ganser, Kon-
stanze Döhner, Andrzej Bartke, Christoph Meissner, Harald Mischak, Zhenyu Ju, and
K Lenhard Rudolph. Proteins induced by telomere dysfunction and dna damage repre-
sent biomarkers of human aging and disease. Proc Natl Acad Sci U S A, 105(32):11299–
11304, Aug 2008. doi: 10.1073/pnas.0801457105. URL http://dx.doi.org/10.1073/pnas.
0801457105. (Cited on pages 3 and 4.)
[41] David Karasik, Serkalem Demissie, L Adrienne Cupples, and Douglas P. Kiel. Disentan-
gling the genetic determinants of human aging: biological age as an alternative to the use
of survival measures. J Gerontol A Biol Sci Med Sci, 60(5):574–587, May 2005. (Cited on
page 3.)
[42] Richard A. Kerber, Elizabeth O’Brien, and Richard M. Cawthon. Gene expression profiles
associated with aging and mortality in humans. Aging Cell, 8(3):239–250, Jun 2009. doi:
10.1111/j.1474-9726.2009.00467.x. URL http://dx.doi.org/10.1111/j.1474-9726.2009.
00467.x. (Cited on page 3.)
[43] Katherine M Keyes, Rebecca L Utz, Whitney Robinson, and Guohua Li. What is a co-
hort effect? comparison of three statistical methods for modeling cohort effects in obesity
prevalence in the united states, 1971-2006. Soc Sci Med, 70(7):1100–1108, Apr 2010. doi:
10.1016/j.socscimed.2009.12.018. URL http://dx.doi.org/10.1016/j.socscimed.2009.
12.018. (Cited on page 43.)
[44] Ji-Soo Kim, Eui-Jin Kim, Hyun-Jung Kim, Ji-Young Yang, Geum-Sook Hwang, and Chan-
Wha Kim. Proteomic and metabolomic analysis of h2o2-induced premature senescent
human mesenchymal stem cells. Exp Gerontol, 46(6):500–510, Jun 2011. doi: 10.1016/j.
exger.2011.02.012. URL http://dx.doi.org/10.1016/j.exger.2011.02.012. (Cited on
page 15.)
[45] Bruce S. Kristal and Yevgeniya I. Shurubor. Metabolomics: opening another window into
aging. Sci Aging Knowledge Environ, 2005(26):pe19, Jun 2005. doi: 10.1126/sageke.2005.26.
pe19. URL http://dx.doi.org/10.1126/sageke.2005.26.pe19. (Cited on pages 10, 13,
and 41.)
[46] Kay A. Lawton, Alvin Berger, Matthew Mitchell, K Eric Milgram, Anne M. Evans, Lining
Guo, Richard W. Hanson, Satish C. Kalhan, John A. Ryals, and Michael V. Milburn. Analy-
sis of the adult human plasma metabolome. Pharmacogenomics, 9(4):383–397, Apr 2008. doi:
10.2217/14622416.9.4.383. URL http://dx.doi.org/10.2217/14622416.9.4.383. (Cited
on pages 6, 13, 14, 16, 39, and 40.)
[47] Georg Löffler and Petro E. Petrides. Biochemie und Pathobiochemie, volume 7. Springer-
Verlag Berlin Heidelberg New York Hongkong Mailand Paris Tokio, 2003. (Cited on
page 10.)
[48] Yashu Liu, Jintang He, Shaoyi Ji, Qingsong Wang, Hai Pu, Tingting Jiang, Lingyao Meng,
Xiuwei Yang, and Jianguo Ji. Comparative studies of early liver dysfunction in senescence-
accelerated mouse using mitochondrial proteomics approaches. Mol Cell Proteomics, 7(9):
1737–1747, Sep 2008. doi: 10.1074/mcp.M800109-MCP200. URL http://dx.doi.org/10.
1074/mcp.M800109-MCP200. (Cited on page 40.)
[49] Yoichi Minami, Takeya Kasukawa, Yuji Kakazu, Masayuki Iigo, Masahiro Sugimoto,
Satsuki Ikeda, Akira Yasui, Gijsbertus T J. van der Horst, Tomoyoshi Soga, and Hi-
roki R. Ueda. Measurement of internal body time by blood metabolomics. Proc Natl
Acad Sci U S A, 106(24):9890–9895, Jun 2009. doi: 10.1073/pnas.0900617106. URL
http://dx.doi.org/10.1073/pnas.0900617106. (Cited on page 13.)
[50] Robert J. Mishur and Shane L. Rea. Applications of mass spectrometry to metabolomics
and metabonomics: detection of biomarkers of aging and of age-related diseases. Mass
Spectrom Rev, 31(1):70–95, 2012. doi: 10.1002/mas.20338. URL http://dx.doi.org/10.
1002/mas.20338. (Cited on pages 8 and 9.)
[51] MIT AgeLab Website, 2012. URL http://agelab.mit.edu/disruptive-demographics.
(Cited on page 2.)
bibliography 73
[52] Kirstin Mittelstrass, Janina S. Ried, Zhonghao Yu, Jan Krumsiek, Christian Gieger, Cor-
nelia Prehn, Werner Roemisch-Margl, Alexey Polonikov, Annette Peters, Fabian J. Theis,
Thomas Meitinger, Florian Kronenberg, Stephan Weidinger, Heinz Erich Wichmann,
Karsten Suhre, Rui Wang-Sattler, Jerzy Adamski, and Thomas Illig. Discovery of sexual di-
morphisms in metabolic and genetic biomarkers. PLoS Genet, 7(8):e1002215, Aug 2011. doi:
10.1371/journal.pgen.1002215. URL http://dx.doi.org/10.1371/journal.pgen.1002215.
(Cited on pages 25 and 35.)
[53] Florian L. Muller, Michael S. Lustgarten, Youngmok Jang, Arlan Richardson, and Holly
Van Remmen. Trends in oxidative aging theories. Free Radic Biol Med, 43(4):477–503,
Aug 2007. doi: 10.1016/j.freeradbiomed.2007.03.034. URL http://dx.doi.org/10.1016/
j.freeradbiomed.2007.03.034. (Cited on pages 3 and 5.)
[54] Eiji Naru, Yasukazu Takanezawa, Misako Kobayashi, Yuko Misaki, Kazuhiko Kaji, and
Kumi Arakane. Increased levels of a particular phosphatidylcholine species in senes-
cent human dermal fibroblasts in vitro. Hum Cell, 21(3):70–78, Aug 2008. doi: 10.1111/
j.1749-0774.2008.00052.x. URL http://dx.doi.org/10.1111/j.1749-0774.2008.00052.x.
(Cited on pages 37 and 45.)
[55] Ekaterina Nevedomskaya, Axel Meissner, Sibel Goraler, Monique de Waard, Yanto Rid-
wan, Gerben Zondag, Ingrid van der Pluijm, André M. Deelder, and Oleg A. Mayboroda.
Metabolic profiling of accelerated aging ercc1 d/- mice. J Proteome Res, 9(7):3680–3687, Jul
2010. doi: 10.1021/pr100210k. URL http://dx.doi.org/10.1021/pr100210k. (Cited on
page 15.)
[56] Janne Nikkilä, Marko Sysi-Aho, Andrey Ermolov, Tuulikki Seppänen-Laakso, Olli Simell,
Samuel Kaski, and Matej Oresic. Gender-dependent progression of systemic metabolic
states in early childhood. Mol Syst Biol, 4:197, 2008. doi: 10.1038/msb.2008.34. URL
http://dx.doi.org/10.1038/msb.2008.34. (Cited on pages 14 and 16.)
[57] Robert C. Noland, Timothy R. Koves, Sarah E. Seiler, Helen Lum, Robert M. Lust,
Olga Ilkayeva, Robert D. Stevens, Fausto G. Hegardt, and Deborah M. Muoio. Carni-
tine insufficiency caused by aging and overnutrition compromises mitochondrial per-
formance and metabolic control. J Biol Chem, 284(34):22840–22852, Aug 2009. doi:
10.1074/jbc.M109.032888. URL http://dx.doi.org/10.1074/jbc.M109.032888. (Cited on
page 38.)
[58] Nicole Noren Hooten, Kotb Abdelmohsen, Myriam Gorospe, Ngozi Ejiogu, Alan B. Zon-
derman, and Michele K. Evans. microrna expression patterns reveal differential expres-
sion of target genes with age. PLoS One, 5(5):e10724, 2010. doi: 10.1371/journal.pone.
0010724. URL http://dx.doi.org/10.1371/journal.pone.0010724. (Cited on page 40.)
[59] M. Oresic. Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dys-
function. Nutr Metab Cardiovasc Dis, 19(11):816–824, Dec 2009. doi: 10.1016/j.numecd.2009.
04.018. URL http://dx.doi.org/10.1016/j.numecd.2009.04.018. (Cited on pages 14
and 20.)
[60] G. Paolisso, M. Barbieri, M. Bonafè, and C. Franceschi. Metabolic age modelling: the
lesson from centenarians. Eur J Clin Invest, 30(10):888–894, Oct 2000. (Cited on pages 6
and 36.)
[61] Linda Partridge, Janet Thornton, and Gillian Bates. The new science of ageing. Philos
Trans R Soc Lond B Biol Sci, 366(1561):6–8, Jan 2011. doi: 10.1098/rstb.2010.0298. URL
http://dx.doi.org/10.1098/rstb.2010.0298. (Cited on pages 8 and 13.)
[62] Antti Perheentupa and Ilpo Huhtaniemi. Aging of the human ovary and testis. Mol Cell
Endocrinol, 299(1):2–13, Feb 2009. doi: 10.1016/j.mce.2008.11.004. URL http://dx.doi.
org/10.1016/j.mce.2008.11.004. (Cited on pages 3 and 4.)
[63] M D W. Piper, C. Selman, J. J. McElwee, and L. Partridge. Separating cause from effect:
how does insulin/igf signalling control lifespan in worms, flies and mice? J Intern Med,
263(2):179–191, Feb 2008. doi: 10.1111/j.1365-2796.2007.01906.x. URL http://dx.doi.org/
10.1111/j.1365-2796.2007.01906.x. (Cited on page 8.)
[64] Matthew D W. Piper and Andrzej Bartke. Diet and aging. Cell Metab, 8(2):99–104, Aug
2008. doi: 10.1016/j.cmet.2008.06.012. URL http://dx.doi.org/10.1016/j.cmet.2008.06.
012. (Cited on page 3.)
74 bibliography
[65] Nikolaos Psychogios, David D. Hau, Jun Peng, An Chi Guo, Rupasri Mandal, Souhaila
Bouatra, Igor Sinelnikov, Ramanarayan Krishnamurthy, Roman Eisner, Bijaya Gautam,
Nelson Young, Jianguo Xia, Craig Knox, Edison Dong, Paul Huang, Zsuzsanna Hol-
lander, Theresa L. Pedersen, Steven R. Smith, Fiona Bamforth, Russ Greiner, Bruce Mc-
Manus, John W. Newman, Theodore Goodfriend, and David S. Wishart. The human
serum metabolome. PLoS One, 6(2):e16957, 2011. doi: 10.1371/journal.pone.0016957. URL
http://dx.doi.org/10.1371/journal.pone.0016957. (Cited on page 8.)
[66] R Development Core Team. R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing, Vienna, Austria, 2011. URL http://www.R-project.
org/. ISBN 3-900051-07-0. (Cited on page 22.)
[67] W. Rathmann, K. Strassburger, M. Heier, R. Holle, B. Thorand, G. Giani, and C. Meisinger.
Incidence of type 2 diabetes in the elderly german population and the effect of clinical and
lifestyle risk factors: Kora s4/f4 cohort study. Diabet Med, 26(12):1212–1219, Dec 2009. doi:
10.1111/j.1464-5491.2009.02863.x. URL http://dx.doi.org/10.1111/j.1464-5491.2009.
02863.x. (Cited on page 19.)
[68] Colin Selman and Dominic J. Withers. Mammalian models of extended healthy lifespan.
Philos Trans R Soc Lond B Biol Sci, 366(1561):99–107, Jan 2011. doi: 10.1098/rstb.2010.0243.
URL http://dx.doi.org/10.1098/rstb.2010.0243. (Cited on page 5.)
[69] Andreas Simm and Thomas A. Rando. Tissue ageing: do insights into molecular mech-
anisms of ageing lead to new therapeutic strategies? Exp Gerontol, 43(7):603–604, Jul
2008. doi: 10.1016/j.exger.2008.05.009. URL http://dx.doi.org/10.1016/j.exger.2008.
05.009. (Cited on page 3.)
[70] Andreas Simm, Norbert Nass, Babett Bartling, Britt Hofmann, Rolf-Edgar Silber, and
Alexander Navarrete Santos. Potential biomarkers of ageing. Biol Chem, 389(3):257–
265, Mar 2008. doi: 10.1515/BC.2008.034. URL http://dx.doi.org/10.1515/BC.2008.034.
(Cited on pages 1, 3, and 4.)
[71] Carolyn M. Slupsky, Kathryn N. Rankin, James Wagner, Hao Fu, David Chang, Aalim M.
Weljie, Erik J. Saude, Bruce Lix, Darryl J. Adamko, Sirish Shah, Russ Greiner, Brian D.
Sykes, and Thomas J. Marrie. Investigations of the effects of gender, diurnal variation, and
age in human urinary metabolomic profiles. Anal Chem, 79(18):6995–7004, Sep 2007. doi:
10.1021/ac0708588. URL http://dx.doi.org/10.1021/ac0708588. (Cited on page 16.)
[72] Erica D. Smith, Mitsuhiro Tsuchiya, Lindsay A. Fox, Nick Dang, Di Hu, Emily O. Kerr,
Elijah D. Johnston, Bie N. Tchao, Diana N. Pak, K Linnea Welton, Daniel E L. Promislow,
James H. Thomas, Matt Kaeberlein, and Brian K. Kennedy. Quantitative evidence for
conserved longevity pathways between divergent eukaryotic species. Genome Res, 18(4):
564–570, Apr 2008. doi: 10.1101/gr.074724.107. URL http://dx.doi.org/10.1101/gr.
074724.107. (Cited on page 8.)
[73] Quinlyn A. Soltow, Dean P. Jones, and Daniel E L. Promislow. A network perspective on
metabolism and aging. Integr Comp Biol, 50(5):844–854, Nov 2010. doi: 10.1093/icb/icq094.
URL http://dx.doi.org/10.1093/icb/icq094. (Cited on page 13.)
[74] Tim D. Spector and Frances M K. Williams. The uk adult twin registry (twinsuk). Twin
Res Hum Genet, 9(6):899–906, Dec 2006. doi: 10.1375/183242706779462462. URL http:
//dx.doi.org/10.1375/183242706779462462. (Cited on page 22.)
[75] Karsten Suhre and Christian Gieger. Genetic variation in metabolic phenotypes: study
designs and applications. Nat Rev Genet, 13(11):759–769, Nov 2012. doi: 10.1038/nrg3314.
URL http://dx.doi.org/10.1038/nrg3314. (Cited on pages 9, 10, 11, and 12.)
[76] M. Szibor and J. Holtz. Mitochondrial ageing. Basic Res Cardiol, 98(4):210–218, Jul 2003.
doi: 10.1007/s00395-003-0421-z. URL http://dx.doi.org/10.1007/s00395-003-0421-z.
(Cited on page 3.)
[77] Tarek A. Taha, Thomas D. Mullen, and Lina M. Obeid. A house divided: ceramide,
sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys
Acta, 1758(12):2027–2036, Dec 2006. doi: 10.1016/j.bbamem.2006.10.018. URL http:
//dx.doi.org/10.1016/j.bbamem.2006.10.018. (Cited on page 38.)
bibliography 75
[78] Georgios A. Theodoridis, Helen G. Gika, Elizabeth J. Want, and Ian D. Wilson. Liquid
chromatography-mass spectrometry based global metabolite profiling: a review. Anal
Chim Acta, 711:7–16, Jan 2012. doi: 10.1016/j.aca.2011.09.042. URL http://dx.doi.org/10.
1016/j.aca.2011.09.042. (Cited on page 9.)
[79] Chiharu Tokunaga, Ken-ichi Yoshino, and Kazuyoshi Yonezawa. mtor integrates amino
acid- and energy-sensing pathways. Biochem Biophys Res Commun, 313(2):443–446, Jan 2004.
(Cited on page 8.)
[80] M. J. Toth and A. Tchernof. Lipid metabolism in the elderly. Eur J Clin Nutr, 54 Suppl 3:
S121–S125, Jun 2000. (Cited on pages 5, 6, and 36.)
[81] UN Department of Economic and Social Affairs Population Division. World population
ageing: 1950 – 2050, annex iii profiles of ageing, major areas and regions, 2002. URL http:
//www.un.org/esa/population/publications/worldageing19502050/index.htm. (Cited
on page 2.)
[82] United Nations, Department of Economic and Social Affairs, Population Division. Pop-
ulation ageing and development 2012, 2012. URL http://www.un.org/esa/population/
publications/2012WorldPopAgeingDev_Chart/2012PopAgeingandDev_WallChart.pdf.
(Cited on page 2.)
[83] J. W. Vaupel. Biodemography of human ageing. Nature, 464(7288):536–542, 2010. URL
PM:20336136. DA - 20100325 IS - 1476-4687 (Electronic) IS - 0028-0836 (Linking) LA - eng
PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support,
Non-U.S. Gov’t PT - Review SB - IM. (Cited on page 2.)
[84] Nawaporn Vinayavekhin, Edwin A. Homan, and Alan Saghatelian. Exploring disease
through metabolomics. ACS Chem Biol, 5(1):91–103, Jan 2010. doi: 10.1021/cb900271r.
URL http://dx.doi.org/10.1021/cb900271r. (Cited on pages 10 and 11.)
[85] M. Virgili, D. Necchi, E. Scherini, and A. Contestabile. Increase of the ornithine decarboxy-
lase/polyamine system and transglutaminase upregulation in the spinal cord of aged rats.
Neurosci Lett, 309(1):62–66, Aug 2001. (Cited on page 40.)
[86] Yulan Wang, Dennis Lawler, Brian Larson, Ziad Ramadan, Sunil Kochhar, Elaine Holmes,
and Jeremy K. Nicholson. Metabonomic investigations of aging and caloric restriction in
a life-long dog study. J Proteome Res, 6(5):1846–1854, May 2007. doi: 10.1021/pr060685n.
URL http://dx.doi.org/10.1021/pr060685n. (Cited on page 15.)
[87] Rui Wang-Sattler, Yao Yu, Kirstin Mittelstrass, Eva Lattka, Elisabeth Altmaier, Christian
Gieger, Karl H. Ladwig, Norbert Dahmen, Klaus M. Weinberger, Pei Hao, Lei Liu, Yixue Li,
H-Erich Wichmann, Jerzy Adamski, Karsten Suhre, and Thomas Illig. Metabolic profiling
reveals distinct variations linked to nicotine consumption in humans–first results from
the kora study. PLoS One, 3(12):e3863, 2008. doi: 10.1371/journal.pone.0003863. URL
http://dx.doi.org/10.1371/journal.pone.0003863. (Cited on page 32.)
[88] Klaus M. Weinberger, Armin Graber, and Jörg Katzenberger. Targeted metabolomics.
BIOspektrum, 02:231–232, 2006. (Cited on pages 10 and 12.)
[89] Geoffrey B. West and Aviv Bergman. Toward a systems biology framework for under-
standing aging and health span. J Gerontol A Biol Sci Med Sci, 64(2):205–208, Feb 2009.
doi: 10.1093/gerona/gln066. URL http://dx.doi.org/10.1093/gerona/gln066. (Cited
on page 13.)
[90] R. E. Williams, E. M. Lenz, J. S. Lowden, M. Rantalainen, and I. D. Wilson. The me-
tabonomics of aging and development in the rat: an investigation into the effect of
age on the profile of endogenous metabolites in the urine of male rats using 1h nmr
and hplc-tof ms. Mol Biosyst, 1(2):166–175, Jul 2005. doi: 10.1039/b500852b. URL
http://dx.doi.org/10.1039/b500852b. (Cited on page 15.)
[91] David S. Wishart, Craig Knox, An Chi Guo, Roman Eisner, Nelson Young, Bijaya Gau-
tam, David D. Hau, Nick Psychogios, Edison Dong, Souhaila Bouatra, Rupasri Mandal,
Igor Sinelnikov, Jianguo Xia, Leslie Jia, Joseph A. Cruz, Emilia Lim, Constance A. Sob-
sey, Savita Shrivastava, Paul Huang, Philip Liu, Lydia Fang, Jun Peng, Ryan Fradette,
Dean Cheng, Dan Tzur, Melisa Clements, Avalyn Lewis, Andrea De Souza, Azaret Zu-
niga, Margot Dawe, Yeping Xiong, Derrick Clive, Russ Greiner, Alsu Nazyrova, Rustem
Shaykhutdinov, Liang Li, Hans J. Vogel, and Ian Forsythe. Hmdb: a knowledgebase for
the human metabolome. Nucleic Acids Res, 37(Database issue):D603–D610, Jan 2009. doi:
10.1093/nar/gkn810. URL http://dx.doi.org/10.1093/nar/gkn810. (Cited on page 10.)
76 bibliography
[92] Shi Fang Yan, Vivette D’Agati, Ann Marie Schmidt, and Ravichandran Ramasamy. Recep-
tor for advanced glycation endproducts (rage): a formidable force in the pathogenesis of
the cardiovascular complications of diabetes & aging. Curr Mol Med, 7(8):699–710, Dec
2007. (Cited on page 3.)
[93] Shikai Yan, Bin Wu, Zhongying Lin, Huizi Jin, Jianhua Huang, Yun Yang, Xinmin Zhang,
Ziyin Shen, and Weidong Zhang. Metabonomic characterization of aging and investiga-
tion on the anti-aging effects of total flavones of epimedium. Mol Biosyst, 5(10):1204–1213,
Oct 2009. doi: 10.1039/b816407j. URL http://dx.doi.org/10.1039/b816407j. (Cited on
pages 11, 15, 39, and 40.)
[94] Zhonghao Yu, Gabi Kastenmüller, Ying He, Petra Belcredi, Gabriele Möller, Cornelia
Prehn, Joaquim Mendes, Simone Wahl, Werner Roemisch-Margl, Uta Ceglarek, Alexey
Polonikov, Norbert Dahmen, Holger Prokisch, Lu Xie, Yixue Li, H-Erich Wichmann, An-
nette Peters, Florian Kronenberg, Karsten Suhre, Jerzy Adamski, Thomas Illig, and Rui
Wang-Sattler. Differences between human plasma and serum metabolite profiles. PLoS
One, 6(7):e21230, 2011. doi: 10.1371/journal.pone.0021230. URL http://dx.doi.org/10.
1371/journal.pone.0021230. (Cited on page 44.)
[95] Guangju Zhai, Rui Wang-Sattler, Deborah J. Hart, Nigel K. Arden, Alan J. Hakim, Thomas
Illig, and Tim D. Spector. Serum branched-chain amino acid to histidine ratio: a novel
metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis, 69(6):1227–1231, Jun
2010. doi: 10.1136/ard.2009.120857. URL http://dx.doi.org/10.1136/ard.2009.120857.
(Cited on pages 12 and 32.)
[96] Xianrong Zhang, Huilang Liu, Junfang Wu, Xu Zhang, Maili Liu, and Yong Wang.
Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in
rats. Neurochem Int, 54(8):481–487, Jul 2009. doi: 10.1016/j.neuint.2009.02.004. URL
http://dx.doi.org/10.1016/j.neuint.2009.02.004. (Cited on page 15.)
[97] Xiaochun Zhu, Molly M. Gallogly, John J. Mieyal, Vernon E. Anderson, and Lawrence M.
Sayre. Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal.
Chem Res Toxicol, 22(6):1050–1059, Jun 2009. doi: 10.1021/tx9000144. URL http://dx.doi.
org/10.1021/tx9000144. (Cited on page 40.)
colophon
This document was typeset using the typographical look-and-feel classicthesis for LATEX
typesetting program developed by André Miede. The style was inspired by Robert Bringhurst’s
seminal book on typography “The Elements of Typographic Style”.
Final Version as of July 1, 2015 (classicthesis version 1.0).

BD E C L A R AT I O N – E I D E S S TAT T L I C H E V E R S I C H E R U N G
Ich erkläre an Eides statt,
dass ich die vorliegende Dissertation mit dem Thema
“Metabolomics and Aging”
selbständig verfasst, mich außer der angegebenen keiner weiteren Hilfsmittel bedient und
alle Erkenntnisse, die aus dem Schrifttum ganz oder annähernd übernommen sind, als solche
kenntlich gemacht und nach ihrer Herkunft unter Bezeichnung der Fundstelle einzeln nachge-
wiesen habe.
Ich erkläre des Weiteren, dass die hier vorgelegte Dissertation nicht in gleicher oder in
ähnlicher Form bei einer anderen Stelle zur Erlangung eines akademischen Grades eingereicht
wurde.
München/Neuherberg, den
Paula Singmann
79
